Document:

<PAGE>   1
                                   EXHIBIT 10.2

                          SECURITIES PURCHASE AGREEMENT

     SECURITIES PURCHASE AGREEMENT (this "AGREEMENT"), dated as of October 31,
2000, by and among STORAGE COMPUTER CORPORATION, a Delaware corporation, with
headquarters located at 11 Riverside Street, Nashua, New Hampshire 03062
("COMPANY"), and each of the purchasers set forth on the signature pages hereto
(the "BUYERS").

     WHEREAS:

     A.   The Company and the Buyers are executing and delivering this Agreement
in reliance upon the exemption from securities registration afforded by Rule 506
under Regulation D ("REGULATION D") as promulgated by the United States
Securities and Exchange Commission (the "SEC") under the Securities Act of 1933,
as amended (the "1933 ACT");

     B.   The Company has authorized two new series of preferred stock, the
first designated as Series C 8% Convertible Preferred Stock (the "SERIES C
PREFERRED STOCK"), having the rights, preferences and privileges set forth in
the Certificate of Designations, Rights and Preferences attached hereto as
EXHIBIT "A-1" (the "SERIES C CERTIFICATE OF DESIGNATION") and the second
designated as Series D 8% Convertible Preferred Stock (the "SERIES D PREFERRED
STOCK"), having the rights, preferences and privileges set forth in the
Certificate of Designations, Rights and Preferences attached hereto as EXHIBIT
"A-2" (the "SERIES D CERTIFICATE OF DESIGNATION" and, collectively with the
Series C Certificate of Designation, the "CERTIFICATES OF DESIGNATION");

     C.   The Preferred Shares (as defined below) are convertible into shares of
common stock, $.001 par value per share, of the Company (the "COMMON STOCK"),
upon the terms and subject to the limitations and conditions set forth in the
Certificates of Designation;

     D.   The Company has (i) authorized the issuance to the Buyers of warrants,
in the form attached hereto as EXHIBIT "B-1", to purchase One Hundred Eighty-One
Thousand One Hundred Thirty-Two (181,132) shares of Common Stock (the "SERIES C
WARRANTS"), (ii) in the event the Second Closing (as defined below) occurs,
authorized the issuance to the Buyers of warrants, in the form attached hereto
as EXHIBIT "B-2," to acquire a number of shares of Common Stock equal to twenty
percent (20%) multiplied by the quotient equal to $3,000,000 divided by the
lesser of (A) the average of the Closing Prices (as defined in the Certificates
of Designation) for the three (3) consecutive Trading Days (as defined in the
Certificates of Designation) ending one (1) Trading Day prior to the Closing
Date (as defined below) with respect to the Second Closing (as defined below)
and (B) $16.08 (the "SERIES D WARRANTS") and (iii) in the event the conditions
to the Second Closing set forth in Section 7(b) have been satisfied but the
Company elects to exercise its option not to consummate the transactions with
respect to the Second Closing, authorized the issuance to the Buyers of warrants
(the "SECOND CLOSING TERMINATION WARRANTS"), in the form attached hereto as
EXHIBIT "B-3", to acquire a number of shares of Common Stock equal to twenty
percent (20%) multiplied by the quotient equal to $750,000 divided by the lesser
of (A) the average of the Closing Prices for the three (3) Trading Days ending
one (1) Trading Day prior to the date the Company

{MI571764;1}

<PAGE>   2

sends written notice to the Buyers that it is electing not to close the
transactions with respects to the Second Closing and (B) $16.08 (the "IMPLIED
CLOSING PRICE"). The Second Closing Termination Warrants, the Series C Warrants
and Series D Warrants are collectively referred to herein as the "WARRANTS". The
shares of Common Stock issuable upon exercise of or otherwise pursuant to the
Warrants are referred to herein collectively as the "WARRANT SHARES;"

     E.   The Buyers desire to purchase and the Company desires to issue and
sell, upon the terms and conditions set forth in this Agreement, (i) an
aggregate of Twelve Thousand (12,000) shares of Series C Preferred Stock (such
shares, together with any Series C Preferred Stock issued in replacement thereof
or as a dividend thereon or otherwise with respect thereto in accordance with
the terms thereof, being hereinafter collectively referred to as the "SERIES C
PREFERRED SHARES") and an aggregate of Three Thousand (3,000) shares of Series D
Preferred Stock (such shares, together with any shares of Series D Preferred
Stock issued in replacement thereto in accordance with the terms thereof, the
"SERIES D PREFERRED SHARES" and collectively with the Series C Preferred Shares,
the "PREFERRED SHARES") and (ii) Series C Warrants to purchase One Hundred
Eighty-One Thousand One Hundred and Thirty-Two (181,132) shares of Common Stock
and Series D Warrants to purchase a number of shares of Common Stock as
determined above, for an aggregate purchase price of Fifteen Million Dollars
($15,000,000);

     F.   In the event the conditions to the Second Closing set forth in Section
7(b) have been satisfied but the Company elects to exercise its option not to
consummate the transactions with respect to the Second Closing, the Company will
issue Second Closing Termination Warrants to purchase a number of shares of
Common Stock as determined above;

     G.   Each Buyer wishes to purchase, upon the terms and conditions stated in
this Agreement, the number of Preferred Shares and number of Warrants as is set
forth immediately below its name on the signature pages hereto;

     H.   Contemporaneous with the execution and delivery of this Agreement, the
parties hereto are executing and delivering a Registration Rights Agreement, in
the form attached hereto as EXHIBIT "C" (the "REGISTRATION RIGHTS AGREEMENT"),
pursuant to which the Company has agreed to provide certain registration rights
under the 1933 Act and the rules and regulations promulgated thereunder, and
applicable state securities laws; and

     NOW THEREFORE, the Company and each of the Buyers severally (and not
jointly) hereby agree as follows:

     1.   PURCHASE AND SALE OF PREFERRED SHARES AND WARRANTS.

          A.   PURCHASE OF PREFERRED SHARES AND WARRANTS. On each Closing Date
(as defined below), the Company shall issue and sell to each Buyer and each
Buyer severally agrees to purchase from the Company such number of Preferred
Shares and number of Warrants for the aggregate purchase price with respect to
such applicable Closing (as defined herein) as is set forth immediately below
such Buyer's name on the signature pages hereto. The issuance, sale and purchase
of the Preferred Shares, Series C Warrants and Series D Warrants shall take
place at two (2) closings (each a "CLOSING"), the first of which is hereinafter
referred to as the "FIRST CLOSING"

{MI571764;1}
<PAGE>   3
and the second of which is referred to as the "SECOND CLOSING." At the First
Closing, the Company shall issue an aggregate of (i) Twelve Thousand (12,000)
Series C Preferred Shares and (ii) Series C Warrants to purchase One Hundred
Eighty-One Thousand One Hundred Thirty-Two (181,132) shares of Common Stock, for
an aggregate purchase price of Twelve Million Dollars ($12,000,000) (the "FIRST
CLOSING PURCHASE PRICE"). At the Second Closing, which shall occur no later than
July 31, 2001, the Company may, at its option (the "SECOND CLOSING OPTION"),
within three (3) business days of the satisfaction of the conditions set forth
in Section 7(b), issue an aggregate of (i) Three Thousand (3,000) Series D
Preferred Shares and (ii) Series D Warrants to purchase an aggregate number of
shares of Common Stock determined by multiplying twenty percent (20%) by the
quotient equal to $3,000,000 divided by the lesser of (A) the average of the
Closing Bid Prices for the three (3) consecutive Trading Days ending one Trading
Day prior to the Closing Date with respect to the Second Closing and (B) $16.08,
for an aggregate purchase price of Three Million Dollars ($3,000,000) (the
"SECOND CLOSING PURCHASE PRICE" and, collectively with the First Closing
Purchase Price, the "PURCHASE PRICE"). Subject to the satisfaction (or waiver)
of the conditions thereto set forth in Section 6 and Section 7 below, (i) at the
First Closing, the Company shall issue and sell to each Buyer and each Buyer
shall purchase from the Company the number of Series C Preferred Shares and
Series C Warrants which such Buyer is purchasing hereunder and set forth below
such Buyer's name on the signature page hereto and (ii) if the Company elects to
exercise the Second Closing Option in writing within two (2) business days of
the conditions set forth in Section 7(b), at the Second Closing, the Company
shall issue and sell to each Buyer and each Buyer shall purchase from the
Company the number of Series D Preferred Shares and Series D Warrants as is set
forth below such Buyer's name on the signature pages hereto. If the conditions
to the Second Closing set forth in Section 7(b) are satisfied, and the Company
elects not to exercise the Second Closing Option within two (2) business days of
the satisfaction of such condition, the Company shall issue Second Closing
Termination Warrants to purchase a number of shares equal to twenty percent
(20%) multiplied by the quotient equal to $750,000 divided by the Implied
Closing Price at an exercise price equal to the Implied Closing Price multiplied
by 1.35.

          b.   FORM OF PAYMENT. On each Closing Date (as defined below), (i)
each Buyer shall pay the purchase price for the Preferred Shares and the Series
C Warrants and Series D Warrants to be issued and sold to it at each respective
Closing by wire transfer or immediately available funds to the Company in
accordance with the Company's written wiring instructions, against delivery of
duly executed certificates representing such number of Preferred Shares and
Series C Warrants and Series D Warrants which such Buyer is purchasing and (ii)
the Company shall deliver such certificates duly executed on behalf of the
Company, to the Buyer, against delivery of such applicable Purchase Price.

          c.   CLOSING DATE. Subject to the satisfaction (or waiver) of the
conditions thereto set forth in Section 6 and Section 7 below, the date and time
of the issuance and sale of the Preferred Shares and the Warrants pursuant to
this Agreement (the "CLOSING DATE") shall be (i) in the case of the First
Closing, 12:00 noon Eastern Standard Time on October 31, 2000, and (iii) in the
case of the Second Closing, as soon as practicable (but no later than 12:00 noon
Eastern Standard Time on the fifth (5th) Trading Day (as defined in the
Certificates of Designation)) following the satisfaction (or waiver) of the
conditions to the Second Closing set forth in Sections 6 and 7 below (but in no
event later than the fifth (5th) Trading Day following the satisfaction of the
last condition set forth in Section 7(b)) or, in each case, such other mutually
agreed upon time. Notwithstanding anything

{MI571764;1}
<PAGE>   4
to the contrary contained herein, in the event the Second Closing does not occur
prior to July 31, 2001, the parties to this Agreement shall have no further
obligations hereunder with respect to the Second Closing. Each Closing shall
occur on the applicable Closing Date at the offices of Akerman, Senterfitt &
Eidson, P.A., One Southeast Third Avenue, Miami, Florida 33131, or at such other
location as may be agreed to by the parties.

2.   BUYERS' REPRESENTATIONS AND WARRANTIES. Each Buyer severally (and not
jointly) represents and warrants to the Company solely as to such Buyer that:

          a.   INVESTMENT PURPOSE. As of the date hereof, the Buyer is
purchasing the Preferred Shares and the shares of Common Stock issuable upon
conversion of or otherwise pursuant to the Preferred Shares (including, without
limitation, (i) such additional shares of Common Stock as are issuable as a
result of the events described in Articles V, VI.D(ii) or VI.E of the
Certificates of Designation and Section 2(c) of the Registration Rights
Agreement (such shares of Common Stock being collectively referred to herein as
the "CONVERSION SHARES") and the Warrants and the shares of Common Stock
issuable upon exercise of or otherwise pursuant to the Warrants (the "WARRANT
SHARES" and, collectively with the Preferred Shares, Warrants and Conversion
Shares, the "SECURITIES") for its own account and not with a present view
towards the public sale or distribution thereof, except pursuant to sales
registered or exempted from registration under the 1933 Act; PROVIDED, HOWEVER,
that by making the representations herein, the Buyer does not agree to hold any
of the Securities for any minimum or other specific term and reserves the right
to dispose of the Securities at any time in accordance with or pursuant to a
registration statement or an exemption under the 1933 Act.

          b.   ACCREDITED INVESTOR STATUS. The Buyer is an "accredited investor"
as that term is defined in Rule 501(a) of Regulation D (an "ACCREDITED
INVESTOR").

          c.   RELIANCE ON EXEMPTIONS. The Buyer understands that the Securities
are being offered and sold to it in reliance upon specific exemptions from the
registration requirements of United States federal and state securities laws and
that the Company is relying upon the truth and accuracy of, and the Buyer's
compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Buyer set forth herein in order to determine the
availability of such exemptions and the eligibility of the Buyer to acquire the
Securities.

          d.   INFORMATION. The Buyer and its advisors, if any, have been
furnished with all materials relating to the business, finances and operations
of the Company and materials relating to the offer and sale of the Securities
which have been requested by the Buyer or its advisors. The Buyer and its
advisors, if any, have been afforded the opportunity to ask questions of the
Company. Neither such inquiries nor any other due diligence investigation
conducted by Buyer or any of its advisors or representatives shall modify, amend
or affect Buyer's right to rely on the Company's representations and warranties
contained in Section 3 below. The Buyer understands that its investment in the
Securities involves a significant degree of risk.

          e.   GOVERNMENTAL REVIEW. The Buyer understands that no United States
federal or state agency or any other government or governmental agency has
passed upon or made any recommendation or endorsement of the Securities.

{MI571764;1}

<PAGE>   5

          f.   TRANSFER OR RE-SALE. The Buyer understands that (i) except as
provided in the Registration Rights Agreement, the sale or re-sale of the
Securities has not been and is not being registered under the 1933 Act or any
applicable state securities laws, and the Securities may not be transferred
unless (a) the Securities are sold pursuant to an effective registration
statement under the 1933 Act, (b) the Buyer shall have delivered to the Company
an opinion of counsel (which opinion shall be in form, substance and scope
customary for opinions of counsel in comparable transactions) to the effect that
the Securities to be sold or transferred may be sold or transferred pursuant to
an exemption from such registration, (c) the Securities are sold or transferred
to an "affiliate" (as defined in Rule 144 promulgated under the 1933 Act (or a
successor rule) ("RULE 144")) of the Buyer who agrees to sell or otherwise
transfer the Securities only in accordance with this Section 2(f) and who is an
Accredited Investor or (d) the Securities are sold pursuant to Rule 144; (ii)
any sale of such Securities made in reliance on Rule 144 may be made only in
accordance with the terms of said Rule and further, if said Rule is not
applicable, any re-sale of such Securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the 1933 Act) may require compliance
with some other exemption under the 1933 Act or the rules and regulations of the
SEC thereunder; and (iii) neither the Company nor any other person is under any
obligation to register such Securities under the 1933 Act or any state
securities laws or to comply with the terms and conditions of any exemption
thereunder (in each case, other than pursuant to the Registration Rights
Agreement). Notwithstanding the foregoing or anything else contained herein to
the contrary, the Securities may be pledged as collateral in connection with a
BONA FIDE margin account or other lending arrangement.

          g.   LEGENDS. The Buyer understands that the Preferred Shares and the
Warrants and, until such time as the Conversion Shares and Warrant Shares have
been registered under the 1933 Act as contemplated by the Registration Rights
Agreement or otherwise may be sold pursuant to Rule 144 without any restriction
as to the number of securities as of a particular date that can then be
immediately sold, the Conversion Shares and Warrant Shares, may bear a
restrictive legend in substantially the following form (and a stop-transfer
order may be placed against transfer of the certificates for such Securities):

          "The securities represented by this certificate have not been
          registered under the Securities Act of 1933, as amended. The
          securities may not be sold, transferred or assigned in the absence of
          an effective registration statement for the securities under said Act,
          or an opinion of counsel, in form, substance and scope customary for
          opinions of counsel in comparable transactions, that registration is
          not required under said Act or unless sold pursuant to Rule 144 under
          said Act."

          The legend set forth above shall be removed and the Company shall
issue a certificate without such legend to the holder of any Security upon which
it is stamped, if, unless otherwise required by applicable state securities
laws, (a) such Security is registered for sale under an effective registration
statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144
without any restriction as to the number of securities as of a particular date
that can then be immediately sold, or (b) such holder provides the Company with
an opinion of counsel, in form, substance and scope customary for opinions of
counsel in comparable transactions, to the effect that

{MI571764;1}
<PAGE>   6
a public sale or transfer of such Security may be made without registration
under the 1933 Act and such sale or transfer is effected or (c) such holder
provides the Company with reasonable assurances that such Security can be sold
pursuant to Rule 144. The Buyer agrees to sell all Securities, including those
represented by a certificate(s) from which the legend has been removed, in
compliance with applicable prospectus delivery requirements, if any.

          h.   AUTHORIZATION; ENFORCEMENT. This Agreement and the Registration
Rights Agreement have been duly and validly authorized. This Agreement has been
duly executed and delivered on behalf of the Buyer, and this Agreement
constitutes, and upon execution and delivery by the Buyer of the Registration
Rights Agreement, such agreement will constitute, valid and binding agreements
of the Buyer enforceable in accordance with their terms.

          i.   RESIDENCY. The Buyer is a resident of the jurisdiction set forth
immediately below such Buyer's name on the signature pages hereto.

     3.   REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company represents
and warrants to each Buyer, subject to such exceptions as are specifically
disclosed in the disclosure statement (referencing the appropriate schedule or
section number) supplied by Company to the Buyers and dated the date hereof (the
"Disclosure Statement"), as follows:

          a.   ORGANIZATION AND QUALIFICATION. The Company and each of its
Subsidiaries (as defined below), if any, is a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction in
which it is incorporated, with full power and authority (corporate and other) to
own, lease, use and operate its properties and to carry on its business as and
where now owned, leased, used, operated and conducted. SCHEDULE 3(A) of the
Disclosure Statement sets forth a list of all of the Subsidiaries of the Company
and the jurisdiction in which each is incorporated. The Company and each of its
Subsidiaries is duly qualified as a foreign corporation to do business and is in
good standing in every jurisdiction in which its ownership or use of property or
the nature of the business conducted by it makes such qualification necessary
except where the failure to be so qualified or in good standing would not have a
Material Adverse Effect. "MATERIAL ADVERSE EFFECT" means any material adverse
effect on (i) the Securities, (ii) the business, operations, assets, financial
condition or prospects of the Company and its Subsidiaries, if any, taken as a
whole, (iii) the transactions contemplated hereby or by the agreements or
instruments to be entered into in connection herewith or (iv) the authority or
the ability of the Company to perform its obligation under this Agreement, the
Registration Rights Agreement, the Certificates of Designation or the Warrants.
"SUBSIDIARIES" means any corporation or other organization, whether incorporated
or unincorporated, in which the Company owns, directly or indirectly, any equity
or other ownership interest.

          b.   AUTHORIZATION; ENFORCEMENT. (i) The Company has all requisite
corporate power and authority to file and perform its obligations under the
Certificates of Designation and to enter into and perform this Agreement, the
Registration Rights Agreement and the Warrants and to consummate the
transactions contemplated hereby and thereby and to issue the Securities, in
accordance with the terms hereof and thereof, (ii) the execution and delivery of
this Agreement, the Registration Rights Agreement and the Warrants by the
Company, the filing of the Certificates of

{MI571764;1}
<PAGE>   7
Designation and the consummation by it of the transactions contemplated hereby
and thereby (including without limitation, the issuance of the Preferred Shares
and the Warrants and the issuance and reservation for issuance of the Conversion
Shares issuable upon conversion of or otherwise pursuant to the Preferred Shares
and the Warrant Shares issuable upon exercise of or otherwise pursuant to the
Warrants) have been duly authorized by the Company's Board of Directors and no
further consent or authorization of the Company, its Board of Directors, or its
stockholders is required (except for 20% Rule Approval and Authorization
Approval), (iii) this Agreement has been duly executed and delivered by the
Company, and (iv) this Agreement constitutes, and upon execution and delivery by
the Company of the Registration Rights Agreement and the Warrants and upon
execution and filing of the Certificates of Designation, each of such agreements
and instruments will constitute, a legal, valid and binding obligation of the
Company enforceable against the Company in accordance with its terms.

          c.   CAPITALIZATION. As of the date hereof, the authorized capital
stock of the Company consists of (i) 25,000,000 shares of Common Stock of which
14,670,788 shares are issued and outstanding, 3,232,946 shares are reserved for
issuance pursuant to the Company's stock option plans, 3,815,000 shares are
reserved for issuance pursuant to securities (other than the Preferred Shares
and the Warrants) exercisable for, or convertible into or exchangeable for
shares of Common Stock and 2,144,660 (1.5X currently required) shares are
reserved for issuance upon conversion of the Preferred Shares and exercise of
the Warrants (subject to adjustment pursuant to the Company's covenant set forth
in Section 4(h) below); and (ii) 1,000,000 shares of preferred stock, 90,000 of
which are designated as Series A Convertible Preferred Stock of which 45,000 are
issued and outstanding, 20,000 of which are designated as Series B Convertible
Preferred Stock of which 20,000 are issued and outstanding, and 12,000 of which
are designated as Series C 8% Convertible Preferred Stock. All of such
outstanding shares of capital stock are, or upon issuance will be, duly
authorized, validly issued, fully paid and nonassessable. No shares of capital
stock of the Company are subject to preemptive rights or any other similar
rights of the stockholders of the Company or any liens or encumbrances imposed
through the actions or failure to act of the Company. Except as disclosed in
SCHEDULE 3(C) of the Disclosure Statement, as of the effective date of this
Agreement, (i) there are no outstanding options, warrants, scrip, rights to
subscribe for, puts, calls, rights of first refusal, agreements, understandings,
claims or other commitments or rights of any character whatsoever relating to,
or securities or rights convertible into or exchangeable for any shares of
capital stock of the Company or any of its Subsidiaries, or arrangements by
which the Company or any of its Subsidiaries is or may become bound to issue
additional shares of capital stock of the Company or any of its Subsidiaries,
(ii) there are no agreements or arrangements under which the Company or any of
its Subsidiaries is obligated to register the sale of any of its or their
securities under the 1933 Act (except the Registration Rights Agreement) and
(iii) there are no anti-dilution or price adjustment provisions contained in any
security issued by the Company (or in any agreement providing rights to security
holders) that will be triggered by the issuance of the Preferred Shares, the
Warrants, the Conversion Shares or Warrant Shares. The Company has furnished to
the Buyer true and correct copies of the Company's Certificate of Incorporation
as in effect on the date hereof ("CERTIFICATE OF INCORPORATION"), the Company's
By-laws, as in effect on the date hereof (the "BY-LAWS"), and the terms of all
securities convertible into or exercisable for Common Stock of the Company and
the material rights of the holders thereof in respect thereto. The Company shall
provide the Buyer with a written update of this representation signed by the
Company's Chief Executive or Chief Financial Officer on behalf of the Company as
of the Closing Date.

{MI571764;1}

<PAGE>   8

          d.   ISSUANCE OF SHARES. The Preferred Shares are duly authorized and,
upon issuance in accordance with the terms of this Agreement, will be validly
issued, fully paid and non-assessable, and free from all taxes, liens, claims
and encumbrances with respect to the issue thereof and shall not be subject to
preemptive rights or other similar rights of stockholders of the Company and
will not impose personal liability upon the holder thereof. The Conversion
Shares and Warrant Shares are duly authorized and reserved for issuance, and,
when issued upon conversion of or otherwise pursuant to the Preferred Shares and
upon exercise of or otherwise pursuant to the Warrants in accordance with the
terms thereof, will be validly issued, fully paid and non-assessable, and free
from all taxes, liens, claims and encumbrances and will not be subject to
preemptive rights or other similar rights of stockholders of the Company and
will not impose personal liability upon the holder thereof.

          e.   ACKNOWLEDGMENT OF DILUTION. The Company understands and
acknowledges the potentially dilutive effect to the Common Stock upon the
issuance of the Conversion Shares upon conversion of or otherwise pursuant to
the Preferred Shares and upon issuance of the Warrant Shares upon exercise of or
otherwise pursuant to the Warrants. The Company's directors and executive
officers have studied and fully understand the nature of the Securities being
sold hereunder. The Company further acknowledges that its obligation to issue
Conversion Shares and Warrant Shares upon conversion of the Preferred Shares or
exercise of the Warrants in accordance with this Agreement, the Certificates of
Designation and the Warrants is absolute and unconditional regardless of the
dilutive effect that such issuance may have on the ownership interests of other
stockholders of the Company. Taking the foregoing into account, the Company's
Board of Directors has determined, in its good faith business judgment, that the
issuance of the Securities hereunder and under the Certificates of Designation
and the Warrants and the consummation of the transactions contemplated hereby
and thereby are in the best interest of the Company and its stockholders.

          f.   SERIES OF PREFERRED STOCK. The terms, designations, powers,
preferences and relative, participating and optional or special rights, and the
qualifications, limitations and restrictions of each series of preferred stock
of the Company (other than the Preferred Shares) are as stated in the
Certificates of Incorporation, filed on or prior to the date hereof, and the
Bylaws. The terms, designations, powers, preferences and relative, participating
and optional or special rights, and the qualifications, limitations and
restrictions of the Preferred Shares are as stated in the Certificates of
Designation.

          g.   NO CONFLICTS. The execution, delivery and performance of this
Agreement, the Registration Rights Agreement and the Warrants by the Company and
the consummation by the Company of the transactions contemplated hereby and
thereby (including, without limitation, the filing of the Certificates of
Designation and the issuance and reservation for issuance, as applicable, of the
Preferred Shares, Conversion Shares and Warrant Shares) will not (i) conflict
with or result in a violation of any provision of the Certificate of
Incorporation or By-laws or (ii) violate or conflict with, or result in a breach
of any provision of, or constitute a default (or an event which with notice or
lapse of time or both could become a default) under, or give to others any
rights of termination, amendment, acceleration or cancellation of, any
agreement, indenture, patent, patent license or instrument to which the Company
or any of its Subsidiaries is a party, or (iii) result in a violation

{MI571764;1}
<PAGE>   9
of any law, rule, regulation, order, judgment or decree (including federal and
state securities laws and regulations and regulations of any self-regulatory
organizations to which the Company or its securities are subject) applicable to
the Company or any of its Subsidiaries or by which any property or asset of the
Company or any of its Subsidiaries is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a Material
Adverse Effect). Neither the Company nor any of its Subsidiaries is in violation
of its Certificate of Incorporation, By-laws or other organizational documents
and neither the Company nor any of its Subsidiaries is in default (and no event
has occurred which with notice or lapse of time or both could put the Company or
any of its Subsidiaries in default) under, and neither the Company nor any of
its Subsidiaries has taken any action or failed to take any action that would
give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its Subsidiaries is a party or by which any property or assets of the
Company or any of its Subsidiaries is bound or affected, except for possible
defaults as would not, individually or in the aggregate, have a Material Adverse
Effect. The businesses of the Company and its Subsidiaries, if any, are not
being conducted, and shall not be conducted so long as a Buyer owns any of the
Securities, in violation of any law, ordinance or regulation of any governmental
entity. Except as specifically contemplated by this Agreement and as required
under the 1933 Act and any applicable state securities laws, the Company is not
required to obtain any consent, authorization or order of, or make any filing or
registration with, any court, governmental agency, regulatory agency, self
regulatory organization or stock market or any third party in order for it to
execute, deliver or perform any of its obligations under this Agreement, the
Registration Rights Agreement or the Warrants in accordance with the terms
hereof or thereof or to issue and sell the Preferred Shares and Warrants in
accordance with the terms hereof and to issue the Conversion Shares upon
conversion of or otherwise pursuant to the Preferred Shares and the Warrant
Shares upon exercise of or otherwise pursuant to the Warrants. Except as
disclosed in SCHEDULE 3(G) of the Disclosure Statement, all consents,
authorizations, orders, filings and registrations which the Company is required
to obtain pursuant to the preceding sentence have been obtained or effected on
or prior to the date hereof. The Company is not in violation of the listing
requirements of the American Stock Exchange (the "AMEX") and does not reasonably
anticipate that the Common Stock will be delisted by the AMEX in the foreseeable
future. The Company and its Subsidiaries are unaware of any facts or
circumstances which might give rise to any of the foregoing.

          h.   SEC DOCUMENTS; FINANCIAL STATEMENTS. Except as set forth in
Schedule 3(h) of the Disclosure Statement, since December 31, 1997, the Company
has timely filed all reports, schedules, forms, statements and other documents
required to be filed by it with the SEC pursuant to the reporting requirements
of the Securities Exchange Act of 1934, as amended (the "1934 ACT") (all of the
foregoing filed prior to the date hereof and all exhibits included therein and
financial statements and schedules thereto and documents (other than exhibits to
such documents) incorporated by reference therein, being hereinafter referred to
as the "SEC DOCUMENTS"). The Company has delivered to each Buyer true and
complete copies of the SEC Documents, except for such exhibits and incorporated
documents. As of their respective dates, the SEC Documents complied in all
material respects with the requirements of the 1934 Act and the rules and
regulations of the SEC promulgated thereunder applicable to the SEC Documents,
and none of the SEC Documents, at the time they were filed with the SEC,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the

{MI571764;1}
<PAGE>   10
statements therein, in light of the circumstances under which they were made,
not misleading. None of the statements made in any such SEC Documents is, or has
been, required to be amended or updated under applicable law (except for such
statements as have been amended or updated in subsequent filings prior to the
date hereof). As of their respective dates, the financial statements of the
Company included in the SEC Documents complied as to form in all material
respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto. Such financial statements have been
prepared in accordance with United States generally accepted accounting
principles, consistently applied, during the periods involved (except (i) as may
be otherwise indicated in such financial statements or the notes thereto, or
(ii) in the case of unaudited interim statements, to the extent they may not
include footnotes or may be condensed or summary statements) and fairly present
in all material respects the consolidated financial position of the Company and
its consolidated Subsidiaries as of the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended (subject,
in the case of unaudited statements, to normal year-end audit adjustments).
Except as set forth in the financial statements of the Company included in the
SEC Documents, the Company has no liabilities, contingent or otherwise, other
than (i) liabilities incurred in the ordinary course of business subsequent to
December 31, 1999 and (ii) obligations under contracts and commitments incurred
in the ordinary course of business and not required under generally accepted
accounting principles to be reflected in such financial statements, which,
individually or in the aggregate, are not material to the financial condition or
operating results of the Company.

          i.   ABSENCE OF CERTAIN CHANGES. Since December 31, 1999, there has
been no material adverse change and no material adverse development in the
assets, liabilities, business, properties, operations, financial condition,
results of operations or prospects of the Company or any of its Subsidiaries.

          j.   ABSENCE OF LITIGATION. There is no action, suit, claim,
proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body pending or, to the
knowledge of the Company or any of its Subsidiaries, threatened against or
affecting the Company or any of its Subsidiaries, or their officers or directors
in their capacity as such, that could have a Material Adverse Effect. SCHEDULE
3(J) of the Disclosure Statement contains a complete list and summary
description of any pending or threatened proceeding against or affecting the
Company or any of its Subsidiaries, without regard to whether it would have a
Material Adverse Effect. The Company and its Subsidiaries are unaware of any
facts or circumstances which might give rise to any of the foregoing.

          K.   PATENTS, COPYRIGHTS, ETC.

               (i)  The Company and each of its Subsidiaries owns or possesses
the requisite licenses or rights to use all patents, patent applications, patent
rights, inventions, know-how, trade secrets, trademarks, trademark applications,
service marks, service names, trade names and copyrights ("INTELLECTUAL
PROPERTY") necessary to enable it to conduct its business as now operated (and,
except as set forth in SCHEDULE 3(K) of the Disclosure Statement, to the best of
the Company's knowledge, as presently contemplated to be operated in the
future); there is no claim or action by any person pertaining to, or proceeding
pending, or to the Company's knowledge threatened, which challenges the right of
the Company or of a Subsidiary with respect to any

{MI571764;1}
<PAGE>   11
Intellectual Property necessary to enable it to conduct its business as now
operated (and, except as set forth in SCHEDULE 3(K) of the Disclosure Statement,
to the best of the Company's knowledge, as presently contemplated to be operated
in the future); to the best of the Company's knowledge, the Company's or its
Subsidiaries' current and intended products, services and processes do not
infringe on any Intellectual Property or other rights held by any person; and
the Company is unaware of any facts or circumstances which might give rise to
any of the foregoing. The Company and each of its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value
of their Intellectual Property.

               (ii) All of the Company's computer software and computer
hardware, and other similar or related items of automated, computerized or
software systems that are used or relied on by the Company in the conduct of its
business or that were, or currently are being, sold or licensed by the Company
to customers (collectively, "INFORMATION TECHNOLOGY"), are Year 2000 Compliant.
For purposes of this Agreement, the term "YEAR 2000 COMPLIANT" means, with
respect to the Company's Information Technology, that the Information Technology
is designed to be used prior to, during and after the calendar Year 2000 A.D.,
and the Information Technology used during each such time period will accurately
receive, provide and process date and time data (including, but not limited to,
calculating, comparing and sequencing) from, into and between the 20th and 21st
centuries, including the years 1999 and 2000, and leap-year calculations, and
will not malfunction, cease to function, or provide invalid or incorrect results
as a result of the date or time data, to the extent that other information
technology, used in combination with the Information Technology, properly
exchanges date and time data with it.

          l.   NO MATERIALLY ADVERSE CONTRACTS, ETC. Neither the Company nor any
of its Subsidiaries is subject to any charter, corporate or other legal
restriction, or any judgment, decree, order, rule or regulation which in the
judgment of the Company's officers has or is expected in the future to have a
Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a
party to any contract or agreement which in the judgment of the Company's
officers has or is expected to have a Material Adverse Effect.

          m.   TAX STATUS. Except as set forth on SCHEDULE 3(M) of the
Disclosure Statement, the Company and each of its Subsidiaries has made or filed
all federal, state and foreign income and all other tax returns, reports and
declarations required by any jurisdiction to which it is subject (unless and
only to the extent that the Company and each of its Subsidiaries has set aside
on its books provisions reasonably adequate for the payment of all unpaid and
unreported taxes) and has paid all taxes and other governmental assessments and
charges that are material in amount, shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith
and has set aside on its books provisions reasonably adequate for the payment of
all taxes for periods subsequent to the periods to which such returns, reports
or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the
Company know of no basis for any such claim. Except as set forth on SCHEDULE
3(M) of the Disclosure Statement, the Company has not executed a waiver with
respect to the statute of limitations relating to the assessment or collection
of any foreign, federal, state or local tax. Except as set forth on SCHEDULE
3(M) of the Disclosure Statement, none of the Company's tax returns is presently
being audited by any taxing authority.

{MI571764;1}
<PAGE>   12
          n.   CERTAIN TRANSACTIONS. Except as set forth on SCHEDULE 3(N) of the
Disclosure Statement and except for arm's length transactions pursuant to which
the Company or any of its Subsidiaries makes payments in the ordinary course of
business upon terms no less favorable than the Company or any of its
Subsidiaries could obtain from third parties and other than the grant of stock
options disclosed on Schedule 3(c), none of the officers, directors, or
employees of the Company is presently a party to any transaction with the
Company or any of its Subsidiaries (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, or otherwise requiring payments to or from any
officer, director or such employee or, to the knowledge of the Company, any
corporation, partnership, trust or other entity in which any officer, director,
or any such employee has a substantial interest or is an officer, director,
trustee or partner.

          o.   DISCLOSURE. All information relating to or concerning the Company
or any of its Subsidiaries set forth in this Agreement and provided to the
Buyers pursuant to Section 2(d) hereof and otherwise in connection with the
transactions contemplated hereby is true and correct in all material respects
and the Company has not omitted to state any material fact necessary in order to
make the statements made herein or therein, in light of the circumstances under
which they were made, not misleading. No event or circumstance has occurred or
exists, nor is the Company in possession of any information, with respect to the
Company or any of its Subsidiaries or its or their business, properties,
prospects, operations or financial conditions, which has not been publicly
announced or disclosed but under applicable law, rule or regulation, requires
public disclosure or announcement by the Company (assuming for this purpose that
the Company's reports filed under the 1934 Act are being incorporated into an
effective registration statement filed by the Company under the 1933 Act).

          p.   ACKNOWLEDGMENT REGARDING BUYERS' PURCHASE OF SECURITIES. The
Company acknowledges and agrees that the Buyers are acting solely in the
capacity of arm's length purchasers with respect to this Agreement and the
transactions contemplated hereby. The Company further acknowledges that no Buyer
is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to this Agreement and the transactions contemplated
hereby and that any statement made by any Buyer or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated hereby is not advice or a recommendation and is merely incidental
to the Buyers' purchase of the Securities and has not been relied upon by the
Company, its officers or directors in any way. The Company further represents to
each Buyer that the Company's decision to enter into this Agreement has been
based solely on the independent evaluation of the Company and its
representatives.

          q.   NO INTEGRATED OFFERING. Neither the Company, nor any of its
affiliates, nor any person acting on its or their behalf, has directly or
indirectly made any offers or sales of any security or solicited any offers to
buy any security under circumstances that would require registration under the
1933 Act of the issuance of the Securities to the Buyers. The issuance of the
Securities to the Buyers will not be integrated with any other issuance of the
Company's securities (past, current or future) for purposes of any stockholder
approval provisions applicable to the Company or its securities.

{MI571764;1}

<PAGE>   13

          r.   NO BROKERS. The Company has taken no action which would give rise
to any claim by any person for brokerage commissions, finder's fees or similar
payments relating to this Agreement or the transactions contemplated hereby,
except for dealings with Hartsfield Capital Group, whose commissions and fees
will be paid for by the Company.

          s.   PERMITS; COMPLIANCE. The Company and each of its Subsidiaries is
in possession of all franchises, grants, authorizations, licenses, permits,
easements, variances, exemptions, consents, certificates, approvals and orders
necessary to own, lease and operate its properties and to carry on its business
as it is now being conducted (collectively, the "COMPANY PERMITS"), and there is
no action pending or, to the knowledge of the Company, threatened regarding
suspension or cancellation of any of the Company Permits. Neither the Company
nor any of its Subsidiaries is in conflict with, or in default or violation of,
any of the Company Permits, except for any such conflicts, defaults or
violations which, individually or in the aggregate, would not reasonably be
expected to have a Material Adverse Effect. Since December 31, 1999, neither the
Company nor any of its Subsidiaries has received any notification with respect
to possible conflicts, defaults or violations of applicable laws, except for
notices relating to possible conflicts, defaults or violations, which conflicts,
defaults or violations would not have a Material Adverse Effect.

          t.   ENVIRONMENTAL MATTERS.

               (i)  Except as set forth in SCHEDULE 3(T) of the Disclosure
Statement, there are, to the Company's knowledge, with respect to the Company or
any of its Subsidiaries or any predecessor of the Company, no past or present
violations of Environmental Laws (as defined below), releases of any material
into the environment, actions, activities, circumstances, conditions, events,
incidents, or contractual obligations which may give rise to any common law
environmental liability or any liability under the Comprehensive Environmental
Response, Compensation and Liability Act of 1980 or similar federal, state,
local or foreign laws and neither the Company nor any of its Subsidiaries has
received any notice with respect to any of the foregoing, nor is any action
pending or, to the Company's knowledge, threatened in connection with any of the
foregoing. The term "ENVIRONMENTAL LAWS" means all federal, state, local or
foreign laws relating to pollution or protection of human health or the
environment (including, without limitation, ambient air, surface water,
groundwater, land surface or subsurface strata), including, without limitation,
laws relating to emissions, discharges, releases or threatened releases of
chemicals, pollutants contaminants, or toxic or hazardous substances or wastes
(collectively, "HAZARDOUS MATERIALS") into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials, as well as all
authorizations, codes, decrees, demands or demand letters, injunctions,
judgments, licenses, notices or notice letters, orders, permits, plans or
regulations issued, entered, promulgated or approved thereunder.

               (ii) Other than those that are or were stored, used or disposed
of in compliance with applicable law, no Hazardous Materials are contained on or
about any real property currently owned, leased or used by the Company or any of
its Subsidiaries, and no Hazardous Materials were released on or about any real
property previously owned, leased or used by the Company or any of its
Subsidiaries during the period the property was owned, leased or used by the
Company or any of its Subsidiaries, except in the normal course of the Company's
or any of its Subsidiaries' business.

{MI571764;1}
<PAGE>   14
               (iii) Except as set forth in SCHEDULE 3(t) of the Disclosure
Statement, there are no underground storage tanks on or under any real property
owned, leased or used by the Company or any of its Subsidiaries that are not in
compliance with applicable law.

          u.   TITLE TO PROPERTY. The Company and its Subsidiaries have good and
marketable title in fee simple to all real property and good and marketable
title to all personal property owned by them which is material to the business
of the Company and its Subsidiaries, in each case free and clear of all liens,
encumbrances and defects except such as are described in SCHEDULE 3(u) of the
Disclosure Statement or such as would not have a Material Adverse Effect. Any
real property and facilities held under lease by the Company and its
Subsidiaries are held by them under valid, subsisting and enforceable leases
with such exceptions as would not have a Material Adverse Effect.

          v.   INSURANCE. The Company and each of its Subsidiaries are insured
by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and
customary in the businesses in which the Company and its Subsidiaries are
engaged. Neither the Company nor any such Subsidiary has any reason to believe
that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may
be necessary to continue its business at a cost that would not have a Material
Adverse Effect.

          w.   INTERNAL ACCOUNTING CONTROLS. The Company and each of its
Subsidiaries maintain a system of internal accounting controls sufficient, in
the judgment of the Company's board of directors, to provide reasonable
assurance that (i) transactions are executed in accordance with management's
general or specific authorizations, (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with generally
accepted accounting principles and to maintain asset accountability, (iii)
access to assets is permitted only in accordance with management's general or
specific authorization and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences.

          x.   FOREIGN CORRUPT PRACTICES. Neither the Company, nor any of its
Subsidiaries, nor any director, officer, agent, employee or other person acting
on behalf of the Company or any Subsidiary has, in the course of his actions
for, or on behalf of, the Company, used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expenses relating to
political activity; made any direct or indirect unlawful payment to any foreign
or domestic government official or employee from corporate funds; violated or is
in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977;
or made any bribe, rebate, payoff, influence payment, kickback or other unlawful
payment to any foreign or domestic government official or employee.

          y.   SOLVENCY. The Company (both before and after giving effect to the
transactions contemplated by this Agreement) is solvent (I.E., its assets have a
fair market value in excess of the amount required to pay its probable
liabilities on its existing debts as they become absolute and matured) and
currently the Company has no information that would lead it to

{MI571764;1}
<PAGE>   15
reasonably conclude that the Company would not have the ability to, nor does it
intend to take any action that would impair its ability to, pay its debts from
time to time incurred in connection therewith as such debts mature. The Company
did not receive a qualified opinion from its auditors with respect to its most
recent fiscal year end and does not anticipate or know of any basis upon which
its auditors might issue a qualified opinion in respect of its current fiscal
year.

          z.   NO INVESTMENT COMPANY. The Company is not, and upon the issuance
and sale of the Securities as contemplated by this Agreement and the
Certificates of Designation will not be an "investment company" required to be
registered under the Investment Company Act of 1940 (an "INVESTMENT COMPANY").
The Company is not controlled by an Investment Company.

     4.   COVENANTS.

          a.   BEST EFFORTS. The parties shall use their best efforts to satisfy
timely each of the conditions described in Section 6 and 7 of this Agreement.

          b.   FORM D; BLUE SKY LAWS. The Company agrees to file a Form D with
respect to the Securities as required under Regulation D and to provide a copy
thereof to each Buyer promptly after such filing. The Company shall, on or
before the Closing Date with respect to the First Closing, take such action as
the Company shall reasonably determine is necessary to qualify the Securities
for sale to the Buyers at the Closing pursuant to this Agreement under
applicable securities or "blue sky" laws of the states of the United States (or
to obtain an exemption from such qualification), and shall provide evidence of
any such action so taken to each Buyer on or prior to the Closing Date with
respect to the First Closing.

          c.   REPORTING STATUS; ELIGIBILITY TO USE FORM S-3; PRESS RELEASE. The
Company's Common Stock is registered under Section 12(g) of the 1934 Act. So
long as any Buyer beneficially owns any of the Securities, the Company shall
timely file all reports required to be filed with the SEC pursuant to the 1934
Act, and the Company shall not terminate its status as an issuer required to
file reports under the 1934 Act even if the 1934 Act or the rules and
regulations thereunder would permit such termination. The Company will take all
necessary action to meet the "registrant eligibility" requirements set forth in
the general instructions to Form S-3. The Company shall include in the Company's
Quarterly Report on Form 10-Q for the quarter ended September 30, 2000 (the
"FORM 10-Q") a description of the material terms of the transactions
contemplated hereby (and attach as exhibits thereto this Agreement, the
Registration Rights Agreement, the Certificates of Designation and the
Warrants), which Form 10-Q shall be filed on or prior to November 14, 2000 and,
on the date of filing of such Form 10-Q, shall issue a press release describing
the material terms of the transactions contemplated hereby; PROVIDED, HOWEVER,
that, in the event that the Company releases its quarterly earnings for the
quarter ended September 30, 2000 in a press release prior to the filing of the
Form 10-Q, the Company shall include in such press release the material terms of
the transactions contemplated hereby. The press release and Form 10-Q shall be
subject to prior review by the Buyers.

          d.   USE OF PROCEEDS. The Company shall use the proceeds from the sale
of the Preferred Shares and the Warrants in the manner set forth in SCHEDULE
4(d) of the Disclosure Statement attached hereto and made a part hereof and
shall not, directly or indirectly, use such

{MI571764;1}
<PAGE>   16
proceeds for any loan to or investment in any other corporation, partnership,
enterprise or other person (except in connection with its currently existing
direct or indirect Subsidiaries).

          e.   ADDITIONAL EQUITY CAPITAL; RIGHT OF FIRST OFFER. Subject to the
exceptions described below, the Company will not, without the prior written
consent of a majority-in-interest of the Buyers, negotiate or contract with any
party to obtain additional equity financing (including debt financing with an
equity component), during the period (the "LOCK-UP PERIOD") beginning on the
Closing Date with respect to the First Closing and ending ninety (90) days from
the date the Registration Statement (as defined in the Registration Rights
Agreement) is declared effective (subject to extension for any days in which
sales of all of the Registrable Securities (as defined in the Registration
Rights Agreement) cannot be made pursuant to the Registration Statement (as
defined in the Registration Rights Agreement) occurring after the date on which
such Registration Statement is first declared effective by the SEC). In
addition, subject to the exceptions described below and subject to the rights of
first refusal set forth in (i) Section 4(g) of the Securities Purchase Agreement
dated May 1, 2000 between the Company and the purchasers listed therein, (ii)
Section 4(g) of the Securities Purchase Agreement dated August 28, 2000 between
the Company and the purchasers listed therein and (iii) Section 4(g) of the
Securities Purchase Agreement dated September 28, 2000 between the Company and
the purchasers listed therein, the Company will not conduct any equity financing
(including debt with an equity component) ("FUTURE OFFERINGS") during the period
beginning on the Closing Date with respect to the First Closing and ending
ninety (90) days after the end of the Lock-up Period (subject to extension for
any days in which sales of all of the Registrable Securities cannot be made
pursuant to the Registration Statement occurring after the date on which such
Registration Statement is first declared effective by the SEC) unless it shall
have first delivered to each Buyer, at least fifteen (15) business days prior to
the closing of such Future Offering, written notice describing the proposed
Future Offering, including the terms and conditions thereof and proposed
definitive documentation to be entered into in connection therewith, and
providing each Buyer an option during the ten (10) Trading Day period following
delivery of such notice to purchase its pro rata share (based on the ratio that
the aggregate purchase price of the Preferred Stock purchased by it hereunder
bears to the aggregate purchase price of the Preferred Stock purchased
hereunder) of the securities being offered in the Future Offering on the same
terms as contemplated by such Future Offering (the limitations referred to in
this sentence and the preceding sentence are collectively referred to as the
"CAPITAL RAISING LIMITATIONS"). In the event the terms and conditions of a
proposed Future Offering are amended in any respect after delivery of the notice
to the Buyers concerning the proposed Future Offering, the Company shall deliver
a new notice to each Buyer describing the amended terms and conditions of the
proposed Future Offering and each Buyer thereafter shall have an option during
the ten (10) Trading Day period following delivery of such new notice to
purchase its pro rata share of the securities being offered on the same terms as
contemplated by such proposed Future Offering, as amended. The foregoing
sentence shall apply to successive amendments to the terms and conditions of any
proposed Future Offering. The Capital Raising Limitations shall not apply to any
transaction involving (i) issuances of securities in a firm commitment
underwritten public offering (excluding a continuous offering pursuant to Rule
415 under the 1933 Act), (ii) issuances of securities as consideration for a
merger, consolidation or purchase of assets, or in connection with any strategic
partnership or joint venture (the primary purpose of which is not to raise
equity capital), or in connection with the disposition or acquisition of a
business, product or license by the Company or (iii) issuance of securities in a
private placement of Common Stock in which the Company will (A) raise between
Fifteen Million Dollars

{MI571764;1}
<PAGE>   17
($15,000,000) and Twenty Million Dollars ($20,000,000) (the "INVESTMENT
AMOUNT"), (B) sell the Common Stock at a price per share no less than ninety
percent (90%) of the Closing Bid Price (as defined in the Certificates of
Designation) on the date prior to the execution of such binding agreement
evidencing such transaction (the "PRIVATE PLACEMENT PURCHASE PRICE"), (C) issue
to the purchaser of such Common Stock warrants (1) to purchase an aggregate
number of shares of Common Stock not to exceed such number which is determined
by multiplying 0.35 by the quotient of the Investment Amount divided by the
Private Placement Purchase Price, (2) with an exercise price of no less than
130% of the Private Placement Purchase Price and (3) with a term of not more
than three (3) years and (D) cause the purchasers of such securities to agree
not to sell or engage in any direct or indirect transaction in the securities
(including hedging transactions and short sales) prior to July 31, 2001 and (E)
any Registration Statement covering the shares of Common Stock issued in such
transaction is not filed prior to July 31, 2001. The Capital Raising Limitations
also shall not apply to the issuance of securities upon exercise of conversion
of the Company's options, warrants or other convertible securities outstanding
as of the date hereof or to the grant of additional options or warrants, or the
issuance of additional securities, under any Company stock option or restricted
stock plan approved by the stockholders of the Company.

          f.   EXPENSES. The Company shall reimburse Rose Glen Capital
Management, L.P. ("ROSE GLEN") for all expenses incurred by it in connection
with the negotiation, preparation, execution, delivery and performance of this
Agreement and the other agreements to be executed in connection herewith,
including, without limitation, attorneys' and consultants' fees and expenses and
travel expenses. The Company's obligation to reimburse Rose Glen's expenses
under this Section 4(f) shall be limited to Thirty-Five Thousand Dollars
($35,000) of which Seven Thousand Five Hundred Dollars ($7,500) was advanced
previously.

          g.   FINANCIAL INFORMATION. The Company agrees to send the following
reports to each Buyer until such Buyer transfers, assigns, or sells all of the
Securities: (i) within ten (10) days after the filing with the SEC, a copy of
its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q and any
Current Reports on Form 8-K; (ii) within one (1) day after release, copies of
all press releases issued by the Company or any of its Subsidiaries; and (iii)
contemporaneously with the making available or giving to the stockholders of the
Company, copies of any notices or other information the Company makes available
or gives to such stockholders.

          h.   RESERVATION OF SHARES. The Company shall at all times have
authorized, and reserved for the purpose of issuance, a sufficient number of
shares of Common Stock to provide for the full conversion of the outstanding
Preferred Shares and issuance of the Conversion Shares in connection with the
Preferred Shares (based on the lesser of the Market Price in effect from time to
time and the Fixed Conversion Price in effect from time to time (each as defined
in the Certificates of Designation)) and as otherwise required by the
Certificates of Designation and the full exercise of the Warrants and issuance
of the Warrant Shares in connection therewith (based on the Exercise Price (as
defined in the Warrants) of the Warrants in effect from time to time). The
Company shall not reduce the number of shares of Common Stock reserved for
issuance upon conversion of or otherwise pursuant to the Preferred Shares and
upon exercise of or otherwise pursuant to the Warrants without the consent of
each Buyer. Prior to the Authorization Date (as defined below), the Company
shall at all times reserve a minimum of 2,144,660 shares of its authorized but
unissued Common Stock for issuance, the full conversion of the Preferred Shares
and

{MI571764;1}
<PAGE>   18
full exercise of the Warrants. After the Authorization Date, the Company shall
use its best efforts at all times to maintain the number of shares of Common
Stock so reserved for issuance at no less than two (2) times the number that is
then actually issuable upon full conversion of the Preferred Shares (based on
the lesser of the Market Price in effect from time to time and the Fixed
Conversion Price in effect from time to time (each as defined in the
Certificates of Designation) and full exercise of the Warrants (based on the
Exercise Price (as defined in the Warrants) of the Warrants in effect from time
to time). If at any time the number of shares of Common Stock authorized and
reserved for issuance is below the number of Conversion Shares issued and
issuable upon conversion of or otherwise pursuant to the Preferred Shares (based
on the lesser of the Market Price in effect from time to time and the Fixed
Conversion Price in effect from time to time (each as defined in the
Certificates of Designation) and the aggregate number of Warrant Shares issued
and issuable upon exercise of or otherwise pursuant to the Warrants (based on
the Exercise Price (as defined in the Warrants) of the Warrants in effect from
time to time), the Company will promptly take all corporate action necessary to
authorize and reserve a sufficient number of shares, including, without
limitation, calling a special meeting of stockholders to authorize additional
shares to meet the Company's obligations under this Section 4(h), in the case of
an insufficient number of authorized shares, and using its best efforts to
obtain stockholder approval of an increase in such authorized number of shares.

          i.   LISTING. The Company shall promptly secure the listing of the
Conversion Shares and Warrant Shares upon each national securities exchange or
automated quotation system, if any, upon which shares of Common Stock are then
listed (subject to official notice of issuance) and, so long as any Buyer owns
any of the Securities, shall maintain, so long as any other shares of Common
Stock shall be so listed, such listing of all Conversion Shares and Warrant
Shares from time to time issuable upon conversion of or otherwise pursuant to
the Preferred Shares or exercise of or otherwise pursuant to the Warrants. The
Company will obtain and, so long as any Buyer owns any of the Securities,
maintain the listing and trading of its Common Stock on AMEX, the Nasdaq
National Market ("NASDAQ"), the Nasdaq SmallCap Market ("NASDAQ SMALLCAP") or
the New York Stock Exchange ("NYSE") and will comply in all respects with the
Company's reporting, filing and other obligations under the bylaws or rules of
the National Association of Securities Dealers ("NASD") and such exchanges, as
applicable. The Company shall promptly provide to each Buyer copies of any
notices it receives from AMEX and any other exchanges or quotation systems on
which the Common Stock is then listed regarding the continued eligibility of the
Common Stock for listing on such exchanges and quotation systems.

          j.   CORPORATE EXISTENCE. So long as a Buyer beneficially owns any
Preferred Shares or Warrants, the Company shall maintain its corporate existence
and shall not merge, consolidate or sell all or substantially all of the
Company's assets, except in the event of a merger or consolidation or sale of
all or substantially all of the Company's assets, where (i) the successor or
acquiring entity and, if an entity different from the successor or acquiring
entity, the entity whose securities into which the Preferred Shares shall become
convertible pursuant to Article VI.C(ii) of the Certificates of Designation), in
such transaction assumes the Company's obligations hereunder and under the
agreements and instruments entered into in connection herewith (including the
Certificates of Designation and the Warrants) and (ii) the entity whose
securities into which the Preferred Shares shall become convertible pursuant to
Article VI.C(ii) of the Certificates of

{MI571764;1}
<PAGE>   19
Designation is a publicly traded corporation whose Common Stock is listed for
trading on Nasdaq, Nasdaq SmallCap, NYSE or AMEX.

          k.   NO INTEGRATION. The Company shall not make any offers or sales of
any security (other than the Securities) under circumstances that would require
registration of the Securities being offered or sold hereunder under the 1933
Act or cause the offering of Securities to be integrated with any other offering
of securities by the Company for the purpose of any stockholder approval
provision applicable to the Company or its securities.

          l.   STOCKHOLDER APPROVAL. The Company shall hold an annual or special
meeting of its stockholders (the "STOCKHOLDERS' MEETING") no later than May 31,
2001 and obtain at such meeting such approvals of the Company's stockholders as
may be required to (i) issue all of the shares of Common Stock issuable upon
conversion and exercise of, or otherwise with respect to, the Preferred Shares
and Warrants in accordance with applicable law and the rules and regulations of
AMEX (including Section 713 of the AMEX Listing Standards, Policies and
Requirements) (the "20% RULE APPROVAL") and (ii) increase the authorized shares
of Common Stock of the Company to at least 50,000,000 shares (the "AUTHORIZATION
APPROVAL"). The date of the Authorization Approval shall be referred to as the
"AUTHORIZATION DATE." The Company shall comply with the filing and disclosure
requirements of Section 14 under the Exchange Act, and the rules and regulations
thereunder, in connection with the solicitation, acquisition and the disclosure
of the 20% Rule Approval and the Authorization Approval. The Company represents
and warrants that its Board of Directors has approved, and will recommend that
the Company's stockholders approve, the proposal contemplated by this Section
4(l) and shall so indicate such recommendation in the proxy statement used to
solicit the 20% Rule Approval and the Authorization Approval. The Company shall
use its best efforts to cause its officers and directors to vote in favor of the
proposals contemplated by this Section 4(l).

     5.   TRANSFER AGENT INSTRUCTIONS. The Company shall issue irrevocable
instructions to its transfer agent to issue certificates, registered in the name
of each Buyer or its nominee, for the Conversion Shares and Warrant Shares in
such amounts as specified from time to time by each Buyer to the Company upon
conversion of the Preferred Shares or exercise of the Warrants in accordance
with the terms thereof (the "IRREVOCABLE TRANSFER AGENT INSTRUCTIONS"). Prior to
registration of the Conversion Shares and Warrant Shares under the 1933 Act or
the date on which the Conversion Shares or Warrant Shares may be sold pursuant
to Rule 144 without any restriction as to the number of securities as of a
particular date that can then be immediately sold, all such certificates shall
bear the restrictive legend specified in Section 2(g) of this Agreement. The
Company warrants that no instruction other than the Irrevocable Transfer Agent
Instructions referred to in this Section 5, and stop transfer instructions to
give effect to Section 2(f) hereof (in the case of the Conversion Shares and
Warrant Shares, prior to registration of the Conversion Shares and Warrant
Shares under the 1933 Act or the date on which the Conversion Shares or Warrant
Shares may be sold pursuant to Rule 144 without any restriction as to the number
of securities as of a particular date that can then be immediately sold), will
be given by the Company to its transfer agent and that the Securities shall
otherwise be freely transferable on the books and records of the Company as and
to the extent provided in this Agreement and the Registration Rights Agreement.
Nothing in this Section shall affect in any way the Buyer's obligations and
agreement set forth in Section 2(g) hereof to comply with all applicable
prospectus delivery requirements, if any, upon

{MI571764;1}
<PAGE>   20
re-sale of the Securities. If a Buyer provides the Company with (i) an opinion
of counsel, in form, substance and scope customary for opinions in comparable
transactions, to the effect that a public sale or transfer of such Securities
may be made without registration under the 1933 Act and such sale or transfer is
effected or (ii) the Buyer provides reasonable assurances that the Securities
can be sold pursuant to Rule 144, the Company shall permit the transfer, and, in
the case of the Conversion Shares and Warrant Shares, promptly instruct its
transfer agent to issue one or more certificates, free from any restrictive
legend, in such name and in such denominations as specified by such Buyer.

     6.   CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL. The obligation of the
Company hereunder to issue and sell the Preferred Shares and Warrants to a Buyer
at each of the First Closing and the Second Closing is subject to the
satisfaction, at or before the Closing Date in respect of such applicable
Closing, of each of the following conditions thereto, provided that these
conditions are for the Company's sole benefit and may be waived by the Company
at any time in its sole discretion:

          a.   With respect to the First Closing and the Second Closing:

               (i)  The applicable Buyer shall have executed this Agreement and
the Registration Rights Agreement, and delivered the same to the Company.

               (ii) The applicable Buyer shall have delivered the Purchase Price
in accordance with Section 1(b) above.

               (iii) The Series C Certificate of Designation shall have been
accepted for filing with the Secretary of State of the State of Delaware.

               (iv) The representations and warranties of the applicable Buyer
shall be true and correct in all material respects as of the date when made and
as of the Closing Date as though made at that time (except for representations
and warranties that speak as of a specific date, which representations and
warranties shall be true and correct as of such date), and the applicable Buyer
shall have performed, satisfied and complied in all material respects with the
covenants, agreements and conditions required by this Agreement to be performed,
satisfied or complied with by the applicable Buyer at or prior to the Closing
Date.

               (v)  No litigation, statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction
or any self-regulatory organization having authority over the matters
contemplated hereby which prohibits the consummation of any of the transactions
contemplated by this Agreement.

          b.   With respect to the Second Closing:

               (i)  the Series D Certificate of Designation shall have been
accepted for filing with the Secretary of State of the State of Delaware.

{MI571764;1}
<PAGE>   21
     7.   CONDITIONS TO EACH BUYER'S OBLIGATION TO PURCHASE. The obligation of
each Buyer hereunder to purchase the Preferred Shares and Warrants at the
Closing is subject to the satisfaction, at or before the Closing Date, of each
of the following conditions, provided that these conditions are for such Buyer's
sole benefit and may be waived by such Buyer at any time in its sole discretion:

          a.   With respect to the First Closing and the Second Closing:

               (i)  The Company shall have executed this Agreement and the
Registration Rights Agreement, and delivered the same to the Buyer.

               (ii) The Company shall have delivered to such Buyer duly executed
certificates (in such denominations as the Buyer shall request) representing the
Preferred Shares and Warrants purchased at such Closing in accordance with
Section 1(b) above.

               (iii) The Series C Certificate of Designation shall have been
accepted for filing with the Secretary of State of the State of Delaware, and a
copy thereof certified by such Secretary of State shall have been delivered to
such Buyer.

               (iv) The Irrevocable Transfer Agent Instructions, in form and
substance satisfactory to a majority-in-interest of the Buyers, shall have been
delivered to and acknowledged in writing by the Company's Transfer Agent.

               (v)  The representations and warranties of the Company shall be
true and correct in all material respects as of the date when made and as of the
applicable Closing Date as though made at such time (except for representations
and warranties that speak as of a specific date, which representations and
warranties shall be true and correct as of such date) and the Company shall have
performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied
or complied with by the Company at or prior to the applicable Closing Date. The
Buyer shall have received a certificate or certificates, executed by the chief
executive officer of the Company, dated as of the applicable Closing Date, to
the foregoing effect and as to such other matters as may be reasonably requested
by such Buyer including, but not limited to certificates with respect to the
Company's Certificate of Incorporation, By-laws and Board of Directors'
resolutions relating to the transactions contemplated hereby.

               (vi) No litigation, statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction
or any self-regulatory organization having authority over the matters
contemplated hereby which prohibits the consummation of any of the transactions
contemplated by this Agreement.

               (vii) An additional listing application to authorize the
Conversion Shares and the Warrant Shares for quotation on AMEX shall have been
filed with AMEX no later than two (2) Trading Days after the First Closing and
trading in the Common Stock on the AMEX shall not have been suspended by the SEC
or AMEX.

{MI571764;1}
<PAGE>   22
               (viii) The Buyer shall have received an opinions of the Company's
counsel, dated as of the applicable Closing Date, in form, scope and substance
reasonably satisfactory to the Buyer and in substantially the same form as
EXHIBIT "D" attached hereto.

               (ix) The Buyer shall have received an officer's certificate
described in Section 3(c) above, dated as of the applicable Closing Date.

               (x)  The Company shall have received (i) a "Lock-Up" letter and
(ii) a voting agreement, from Theodore Goodlander in the form attached hereto as
EXHIBITS "E" and "F," respectively.

               (xi) The Company shall have received waivers of anti-dilution
adjustments and rights of first refusal, as well as all consents needed for the
sale of the Securities, from The Shaar Fund Ltd.

               (xii) No material adverse change in the business, operations,
assets, financial condition, results of operations, properties or prospects of
the Company and its Subsidiaries, if any, taken as a whole (a "Material Adverse
Change") shall have occurred.

          b.   With respect to the Second Closing:

               (i)  the Series D Certificate of Designation shall have been
accepted for filing with the Secretary of State of the State of Delaware.

               (ii) The Registration Statement (as defined in the Registration
Rights Agreement) shall have been declared effective by the SEC and no stop
order shall have been issued in respect thereof.

               (iii) The number of shares of Common Stock issues or issuable
upon conversion of the Preferred Shares and including the Preferred Shares
issuable at the Second Closing shall not exceed sixty percent (60%) of the
Maximum Share Amount (as defined in the Certificates of Designation.

               (iv) No Mandatory Redemption Event (as defined in the
Certificates of Designation) or "deemed" Liquidating Event (as described in
Article IV.B of the Certificates of Designation) shall have occurred and been
continuing.

               (v)  The Company shall have either (i) obtained the 20% Rule
Approval and Authorization Approval or (ii) reserved for issuance no less than
one and a half (1 1/2) times the number of shares of Common Stock that is then
actually issuable upon full conversion of the Preferred Shares (without regard
to any limitations on conversion contained in the Certificates of Designation
and based on the lesser of the Market Price in effect from time to time and the
Fixed Conversion Price in effect from time to time (each as defined in the
Certificates of Designation) and full exercise of the Warrants (based on the
Exercise Price (as defined in the Warrants) of the Warrants in effect from time
to time).

{MI571764;1}
<PAGE>   23
               (vi) Five (5) Trading Days shall have elapsed since the date on
which the Company filed its Form 10-Q.

     8.   GOVERNING LAW; MISCELLANEOUS.

          a.   GOVERNING LAW. This Agreement shall be governed by and construed
in accordance with the laws of the State of Delaware applicable to agreements
made and to be performed in the State of Delaware (without regard to principles
of conflict of laws). Both parties irrevocably consent to the exclusive
jurisdiction of the United States federal courts and the state courts located in
Delaware with respect to any suit or proceeding based on or arising under this
Agreement, the agreements entered into in connection herewith or the
transactions contemplated hereby or thereby and irrevocably agree that all
claims in respect of such suit or proceeding may be determined in such courts.
Both parties irrevocably waive the defense of an inconvenient forum to the
maintenance of such suit or proceeding. Both parties further agree that service
of process upon a party mailed by first class mail shall be deemed in every
respect effective service of process upon the party in any such suit or
proceeding. Nothing herein shall affect either party's right to serve process in
any other manner permitted by law. Both parties agree that a final
non-appealable judgment in any such suit or proceeding shall be conclusive and
may be enforced in other jurisdictions by suit on such judgment or in any other
lawful manner.

          b.   COUNTERPARTS; SIGNATURES BY FACSIMILE. This Agreement may be
executed in one or more counterparts, all of which shall be considered one and
the same agreement and shall become effective when counterparts have been signed
by each party and delivered to the other party. This Agreement, once executed by
a party, may be delivered to the other party hereto by facsimile transmission of
a copy of this Agreement bearing the signature of the party so delivering this
Agreement.

          c.   HEADINGS. The headings of this Agreement are for convenience of
reference and shall not form part of, or affect the interpretation of, this
Agreement.

          d.   SEVERABILITY. If any provision of this Agreement shall be invalid
or unenforceable in any jurisdiction, such invalidity or unenforceability shall
not affect the validity or enforceability of the remainder of this Agreement or
the validity or enforceability of this Agreement in any other jurisdiction.

          e.   ENTIRE AGREEMENT; AMENDMENTS. This Agreement, the Disclosure
Statement and the instruments referenced herein contain the entire understanding
of the parties with respect to the matters covered herein and therein and,
except as specifically set forth herein or therein, neither the Company nor the
Buyer makes any representation, warranty, covenant or undertaking with respect
to such matters. No provision of this Agreement may be waived or amended other
than by an instrument in writing signed by the party to be charged with
enforcement.

          f.   NOTICES. Any notices required or permitted to be given under the
terms of this Agreement shall be sent by certified or registered mail (return
receipt requested) or delivered

{MI571764;1}
<PAGE>   24
personally or by courier (including a recognized overnight delivery service) or
by facsimile and shall be effective five days after being placed in the mail, if
mailed by regular United States mail, or upon receipt, if delivered personally
or by courier (including a recognized overnight delivery service) or by
facsimile, in each case addressed to a party. The addresses for such
communications shall be:

          If to the Company:

                   Storage Computer Corporation
                   11 Riverside Street
                   Nashua, New Hampshire 03062
                   Attention:  Chief Financial Officer
                   Facsimile:  (603) 889-7232

          With copy to:

                   Peabody & Arnold, LLP
                   50 Rowes Wharf
                   Boston, Massachusetts  021010-3342
                   Attention: William E. Kelly
                   Facsimile: (617) 951-2125

          If to a Buyer: To the address set forth immediately below such Buyer's
name on the signature pages hereto.

           With copy to:

                    Bradley D. Houser
                    Akerman, Senterfitt & Eidson, P.A.
                    SunTrust International Center
                    One Southeast Third Avenue, 28th Floor
                    Miami, Florida  33131-1714
                    Facsimile:  (305) 374-5095

         Each party shall provide notice to the other party of any change in
address.

          g.   SUCCESSORS AND ASSIGNS; COMPANY RIGHT OF FIRST REFUSAL. (i) This
Agreement shall be binding upon and inure to the benefit of the parties and
their successors and assigns. Neither the Company nor any Buyer shall assign
this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, subject to Section 2(f) and
Section 8(g)(ii), any Buyer may assign its rights hereunder to any person that
purchases Securities in a private transaction from a Buyer or to any of its
"affiliates," as that term is defined under the 1934 Act, without the consent of
the Company.

     (ii) No Buyer may at any time transfer its Securities to any person (other
than in a transaction otherwise permitted hereunder or to "affiliates" as that
term is defined in the 1934 Act, to any fund or investment vehicle managed or
controlled by Rose Glen or its affiliates or to a holder

{MI571764;1}
<PAGE>   25
of interests in the Buyer upon liquidation of the Buyer's assets in accordance
with Buyer's governing documents) (a "Proposed Transferee") without first
offering in writing to sell such Preferred Shares and/or Warrants to the Company
first at the same price and upon the same terms and conditions that are proposed
from the transferee (an "Offer"). The Offer shall remain open for a period of
five (5) business days (the "Exercise Period"). If, prior to the end of the
Exercise Period, the Company does not (i) give written notice of its intent to
accept the Offer, and (ii) consummate the purchase of the Preferred Shares
and/or Warrants pursuant to the Offer, such Offer will terminate and the Buyer
shall be permitted to transfer the Securities to the Proposed Transferee
identified in the Offer.

          h.   THIRD PARTY BENEFICIARIES. This Agreement is intended for the
benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other person.

          i.   SURVIVAL. The representations and warranties of the Company and
the agreements and covenants set forth in Sections 3, 4, 5 and 8 shall survive
the closing hereunder notwithstanding any due diligence investigation conducted
by or on behalf of the Buyers. The Company agrees to indemnify and hold harmless
each of the Buyers and all their officers, directors, employees and agents for
loss or damage arising as a result of or related to any breach or alleged breach
by the Company of any of its representations, warranties and covenants set forth
in Sections 3 and 4 hereof or any of its covenants and obligations under this
Agreement or the Registration Rights Agreement, including advancement of
expenses as they are incurred.

          j.   PUBLICITY. The Company and each of the Buyers shall have the
right to review a reasonable period of time before issuance of any press
releases, filings with the SEC, NASD or any stock exchange or interdealer
quotation system, or any other public statements with respect to the
transactions contemplated hereby; PROVIDED, HOWEVER, that the Company shall be
entitled, without the prior approval of each of the Buyers, to make any press
release or public filings with respect to such transactions as is required by
applicable law and regulations (although each of the Buyers shall be consulted
by the Company in connection with any such press release or public filing prior
to its release or public filing and shall be provided with a copy thereof and be
given an opportunity to comment thereon). In addition, the Company agrees that
it will not disclose, and will not include in any public filing or other
announcement, the name of any Buyer, unless expressly agreed to in writing by
such Buyer or unless and until such disclosure is, in the reasonable opinion of
counsel to the Company, required by law or applicable regulation, and then only
to the extent of such requirement.

          k.   FURTHER ASSURANCES. Each party shall do and perform, or cause to
be done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.

          l.   NO STRICT CONSTRUCTION. The language used in this Agreement will
be deemed to be the language chosen by the parties to express their mutual
intent, and no rules of strict construction will be applied against any party.

{MI571764;1}
<PAGE>   26
          m.   REMEDIES. The Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to each Buyer by vitiating the
intent and purpose of the transactions contemplated hereby. Accordingly, the
Company acknowledges that the remedy at law for a breach of its obligations
under this Agreement will be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of this Agreement, that each
Buyer shall be entitled, in addition to all other available remedies in law or
in equity, to an injunction or injunctions to prevent or cure any breaches of
the provisions of this Agreement and to enforce specifically the terms and
provisions of this Agreement, without the necessity of showing economic loss and
without any bond or other security being required.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

{MI571764;1}

<PAGE>   27
          IN WITNESS WHEREOF, the undersigned Buyers and the Company have caused
this Agreement to be duly executed as of the date first above written.

STORAGE COMPUTER CORPORATION

By: /s/ Edward A. Gardner, President
    ------------------------------------
    Edward A. Gardner
    President

RGC INTERNATIONAL INVESTORS, LDC
By: Rose Glen Capital Management, L.P., Investment Manager
    By: RGC General Partner Corp., as General Partner

By: /s/  Wayne D. Bloch
   --------------------------
   Wayne D. Bloch
   Managing Director

RESIDENCE: Cayman Islands

ADDRESS:

         c/o Rose Glen Capital Management, L.P.
         3 Bala Plaza East, Suite 501
         251 St. Asaphs Road
         Bala Cynwyd, PA  19004
         Facsimile:  (610) 617-0570
         Telephone:  (610) 617-5900

AGGREGATE SUBSCRIPTION AMOUNT:

         FIRST CLOSING:
         -------------
         Number of Closing Preferred Shares:     12,000,000
                                                 ------------------
         Number of Closing Warrants:             181,132
                                                 ------------------
         Aggregate Purchase Price:               $12,000,000
                                                 ------------------

         SECOND CLOSING:
         --------------
         Number of Closing Preferred Shares:     3,000,000
                                                 ------------------
         Number of Closing Warrants:             as determined pursuant to
                                                 Section 1(a)
                                                 Aggregate Purchase Price:

{MI571764;1}

                                       27<PAGE>   1

                              EMPLOYMENT AGREEMENT

     This AGREEMENT (the "Agreement") is made as of September 30, 2000 (the
"Effective Date"), by and between Nextera Enterprises, Inc., a Delaware
corporation (the "Company"), and Vincent C. Perro (the "Executive"). In
consideration of the mutual covenants contained in this Agreement, the Company
and the Executive agree as follows:

     1. EMPLOYMENT. Commencing on the Effective Date, the Company agrees to
employ the Executive and the Executive agrees to be employed by the Company on
the terms and conditions set forth in this Agreement.

     2. CAPACITY. During the Term (as hereinafter defined), the Executive shall
serve the Company as its Chief Operating Officer. In such capacity, the
Executive shall perform such services and duties in connection with the
business, affairs and operations of the Company consistent with the Executive's
status as Chief Operating Officer as may be assigned or delegated to the
Executive from time to time by or under the direction and supervision of the
Board of Directors or the Chief Executive Officer of the Company.

     3. TERM. Subject to the provisions of Section 7, the term of employment
under this Agreement (the "Term") shall be for thirty (30) months from the
Effective Date (the "Initial Term") and shall automatically renew for periods of
one (1) year commencing at the expiration of the Initial Term (the "End Date")
and on each subsequent anniversary of the End Date thereafter, unless either the
Executive or the Company, acting through its Board of Directors (the "Board"),
gives written notice to the other not less than sixty (60) days prior to the End
Date or anniversary thereof, as applicable, of such party's election not to
extend the Term.

     4. BOARD SEAT. The parties acknowledge that the Executive is currently
serving as a director of the Company and the Company agrees that, during the
Term, it shall nominate the Executive for re-election as a director and use all
reasonable best efforts to cause the Executive to be re-elected or re-appointed
as a director with a view toward having the Executive serve as a director
throughout the Term, subject to the Executive's right to resign from the Board
of Directors at any time. Any such resignation shall not constitute a
termination of Executive's employment or a termination or breach of this
Agreement.

     5. COMPENSATION AND BENEFITS. The regular compensation and benefits payable
to the Executive under this Agreement shall be as follows:

     (a) SALARY. During the Term, for all services rendered by the Executive
     under this Agreement, the Company shall pay or cause to be paid to the
     Executive a base salary (the "Salary") at an annual rate of Four Hundred
     and Fifty Thousand Dollars ($450,000), commencing on the Effective Date.
     Notwithstanding the foregoing, commencing January 1, 2001, the Company
     shall cause $170,000 per year of the Salary to be paid by Sibson & Company,
     LLC, a Delaware limited liability company (formerly SC/NE, LLC) and
     subsidiary of the Company ("Sibson"), and the balance of the Salary will be
     paid by the Company. The Salary shall be payable in periodic installments
     in accordance with the Company's and Sibson's usual practice for their
     senior executives.

                                       1
<PAGE>   2

     (b) BONUS. The Executive will be eligible for a discretionary bonus
     targeted to be 80% of Salary upon achievement of goals set by the Board of
     Directors. In addition, the Company shall cause Sibson to pay to the
     Executive a bonus for 2000 based on his performance as a Principal of
     Sibson through the Effective Date in an amount, and determined on a basis,
     comparable to the bonuses paid by Sibson to its other top revenue
     generating Principals for 2000.

     (c) STOCK OPTIONS. As of the Effective Date, the Company shall grant to the
     Executive non-qualified options to purchase 400,000 shares of the Company's
     Class A Common Stock at an exercise price equal to the fair market value on
     the Effective Date. Such options will vest at a rate of 25% per year over
     four years on each anniversary of the Effective Date with the first tranche
     vesting one year after the Effective Date. The Company represents that it
     has furnished to the Executive a true and complete copy of any option plan
     and/or any agreement relating to such options on or prior to the Effective
     Date.

     (d) REGULAR BENEFITS. The Executive shall also be entitled to participate
     in the plans listed on "Schedule 1" hereto and any other employee benefit
     plans, medical insurance plans, life insurance plans, disability income
     plans, retirement plans, pension plans, profit sharing plans, vacation
     plans, expense reimbursement plans and other benefit plans which the
     Company or Sibson may from time to time have in effect for all or most of
     its senior executives (collectively, "Benefits"); it being expressly
     understood and agreed that the Executive will continue to participate in
     the Sibson retirement plan and that the Company will pay or cause to be
     paid $30,000 per annum (including for the year 2000) in contributions to
     such plan for the benefit of the Executive. Such participation shall be
     subject to the terms of the applicable plan documents, generally applicable
     policies of the Company and/or Sibson, applicable law and the discretion of
     the Leadership Council of Sibson (the "Leadership Council") or a committee
     thereof (in the case of Sibson's benefit plans), the Board or a committee
     thereof (in the case of the Company's benefit plans), or any administrative
     or other committee provided for in or contemplated by any such plan.
     Nothing contained in this Agreement shall be construed to create any
     obligation on the part of the Company or Sibson to establish any such plan
     or to maintain the effectiveness of any such plan which may be in effect
     from time to time; PROVIDED, HOWEVER, the Benefits offered to the Executive
     shall be substantially similar to those Benefits extended to the Executive
     by Sibson immediately prior to the date hereof and, PROVIDED FURTHER, that
     at any time the Company, in its sole discretion may, or may cause Sibson,
     (A) to modify or terminate any Benefits provided to the Executive as the
     Company deems necessary to provide that any employee Benefit plan and
     related trust intended to be qualified and exempt under Sections 401(a) and
     501(a) of the Internal Revenue Code of 1986, as amended, respectively,
     shall be so qualified and exempt, or (B) to otherwise comply with the
     applicable requirements of the Employee Retirement Income Security Act of
     1974, as amended (or other applicable law). In the event that any Benefits
     are terminated or materially reduced pursuant to the immediately preceding
     proviso, the Company shall provide the Executive with other Benefits or one
     or more cash payments which in the aggregate on an after-tax basis are
     equal to the value of such terminated or materially-reduced Benefits
     through the date of the Executive's termination of employment.

                                       2
<PAGE>   3

     (e) PAST SERVICE. The Executive shall be credited with all past service
     with Sibson & Company, L.P., a Delaware limited partnership (the
     "Partnership") and Sibson in the calculation of all benefits and for all
     other relevant purposes whatsoever where past service or seniority shall be
     considered, subject to any regulatory limitations. For purposes of the
     preceding sentence, the Executive shall be deemed to have begun employment
     with the Company on the date the Executive began employment with the
     Partnership or its predecessors, as applicable.

     (f) VACATION. The Executive's vacation entitlement shall be the same as the
     policy of Sibson immediately prior to the date hereof.

     (g) TAXATION OF PAYMENTS AND BENEFITS. The Company shall undertake to make
     deductions, withholdings and tax reports with respect to payments and
     Benefits under this Agreement to the extent that it reasonably and in good
     faith believes that it is required to make such deductions, withholdings
     and tax reports. Payments under this Agreement shall be in amounts net of
     any such deductions or withholdings. Nothing in this Agreement shall be
     construed to require the Company to make any payments to compensate the
     Executive for any adverse tax effect associated with any payments or
     benefits or for any deduction or withholding from any payment or benefit.

     (h) EXCLUSIVITY OF SALARY AND BENEFITS. The Executive shall not be entitled
     to any payments or benefits other than those provided under this Agreement
     (other than customary business expense reimbursements submitted and
     approved in accordance with Company policy).

     6. EXTENT OF SERVICE. During the Executive's employment under this
Agreement, the Executive shall, subject to the direction and supervision of the
Board, devote substantially all of the Executive's business time, and use the
Executive's best efforts and business judgment, skill and knowledge to the
advancement of the Company's interests and to the discharge of the Executive's
duties and responsibilities under this Agreement. The Executive shall not engage
in any other business activity, except as may be approved by the Company which
approval shall not be unreasonably withheld; provided that nothing in this
Agreement shall be construed as preventing the Executive from:

     (a) investing the Executive's assets in any company or other entity in a
     manner not prohibited by the Non-Compete, Non-Solicitation, Proprietary
     Information, Confidentiality and Inventions Agreement (the "Non-Compete
     Agreement") referred to in Section 8(a) and in such form or manner as shall
     not require any material activities on the Executive's part in connection
     with the operations or affairs of the companies or other entities in which
     such investments are made; or

     (b) engaging in religious, charitable or other community or non-profit
     activities that do not materially impair the Executive's ability to fulfill
     the Executive's duties and responsibilities under this Agreement.

                                       3
<PAGE>   4

     7. TERMINATION AND TERMINATION BENEFITS. Notwithstanding the provisions of
Section 3, the Executive's employment under this Agreement shall terminate under
the following circumstances set forth in this Section 7.

     (a) TERMINATION BY THE COMPANY FOR CAUSE.

          (i) The Executive's employment under this Agreement may be terminated
          for Cause without further liability on the part of the Company
          effective immediately upon a vote of the Board and written notice to
          the Executive. Subject to Section 7(g), only the following shall
          constitute "Cause" for such termination:

               (A) material dishonest statements or acts of the Executive with
               respect to the Company or any affiliate of the Company;

               (B) conviction of the Executive for (x) a felony or (y) any
               misdemeanor involving moral turpitude, deceit, dishonesty or
               fraud; or

               (C) willful and material breach of this Agreement or the
               Non-Compete Agreement by the Executive, gross negligence, willful
               misconduct or willful failure or refusal of the Executive to
               comply with explicit directions of the Board, which directions
               are consistent with Section 2 of this Agreement, in each instance
               after fifteen (15) days written notice and an opportunity to
               cure.

               In making any determination under this Section 7(a), the Board
          shall act fairly and in good faith and shall give the Executive an
          opportunity to appear and be heard at a meeting of the Board or the
          compensation committee of the Board, which meeting may be held
          telephonically at the request of either the Company or the Executive,
          and present evidence on the Executive's behalf.

     (b) TERMINATION BY THE EXECUTIVE. The Executive's employment under this
     Agreement may be terminated by the Executive by written notice to the
     Company at least sixty (60) days prior to such termination.

     (c) TERMINATION BY THE COMPANY WITHOUT CAUSE OR BY THE EXECUTIVE WITH GOOD
     REASON. Subject to the payment of Termination Benefits pursuant to Section
     7(d), the Executive's employment under this Agreement may be terminated by
     the Company without Cause upon written notice to the Executive by a vote of
     the Board or by the Executive with Good Reason upon written notice to the
     Board. For purposes of this Agreement, "Good Reason" shall mean, without
     the Executive's written consent, the occurrence of any of the following
     circumstances:

          (i) the assignment to the Executive of any duties substantially
          inconsistent and adverse with the position of Chief Operating Officer
          of the Company or a significant adverse alteration in the nature or
          status of the Executive's responsibilities or the conditions of the
          Executive's employment as Chief Operating Officer;

                                       4
<PAGE>   5

          (ii) the Company's reduction of the Executive's Salary as in effect on
          the Effective Date or as the same may be increased from time to time
          except for across-the-board salary reductions similarly affecting all
          management personnel of the Company;

          (iii) the Company's failure to continue in effect any material
          compensation or benefit plan in which the Executive participates,
          unless an equitable arrangement (embodied in an ongoing substitute or
          alternative plan) has been made with respect to such plan, or the
          Company's failure to continue the Executive's participation therein
          (or in such substitute or alternative plan) on a basis not materially
          less favorable, both in terms of the amount of benefits provided and
          the level of the Executive's participation relative to other
          participants; or

          (iv) the Company-required relocation of the Executive's residence or
          principal place of business to a location outside of the Manhattan
          business district; provided; however, Executive acknowledges that he
          may be required to spend a substantial amount of time traveling on
          Company business. The Company shall pay for all of Executive's
          reasonable travel and living expenses associated with such travel from
          the New York City metropolitan area;

          (v) the Company's failure to pay to the Executive any portion of the
          Executive's current compensation or to pay to the Executive any
          portion of an installment or deferred compensation under any deferred
          compensation program of the Company within seven (7) days of the date
          such compensation is due;

          (vi) the Company's failure to continue to provide the Executive with
          benefits substantially similar to those enjoyed by the Executive under
          any of the Company's life insurance, medical, health and accident, or
          disability plans in which the Executive participates, the taking of
          any action by the Company which would directly or indirectly
          materially reduce any of such benefits, or the failure by the Company
          to provide the Executive with the number of paid vacation days to
          which the Executive is entitled on the basis of years of service with
          the Company in accordance with the Company's normal vacation policy;
          or (vii) in the event the Company engages in a merger or other
          business combination or a sale of all or substantially all of its
          assets, the failure of any successor to the Company to expressly
          assume the obligations of the Company under this Agreement, except
          that any such successor need not assume the obligations described in
          Section 4 (Board Seat) hereof.

     (d) CERTAIN TERMINATION BENEFITS. Unless otherwise specifically provided in
     this Agreement or otherwise required by law, all compensation and benefits
     payable to the Executive under this Agreement shall terminate on the date
     of termination of the Executive's employment under this Agreement.
     Notwithstanding the foregoing, in the event of termination of the
     Executive's employment with the Company pursuant to Section 7(c) or the
     Company's failure to renew this Agreement as contemplated by Section 7(h),
     subject to the Executive's continuing compliance with his obligations under

                                       5
<PAGE>   6

     the Non-Compete Agreement (other than those under the Section entitled
     "Non-Compete/Exclusivity"), the Company shall provide to the Executive the
     following termination benefits ("Termination Benefits"):

          (i) continuation of the Executive's Salary at the rate then in effect
          pursuant to Section 5(a);

          (ii) (A) a bonus for the year in which the termination occurs pro rata
          for the period of service in such year, based upon (x) the bonus
          amount, if any, paid to the Executive pursuant to Section 5(b) for the
          year preceding the year in which the termination of employment occurs
          or (y) if the termination occurs prior to the determination of an
          annual bonus for such preceding year under this Agreement, the
          targeted bonus of 80% of Salary (such applicable amount under clause
          (x) or (y) being referred to as the "Applicable Bonus"), and (B)
          payments at an annual rate based upon the Applicable Bonus to be paid
          monthly during the period set forth in subsection (iv) below;

          (iii) continuation of all Benefits to the extent authorized by and
          consistent with 29 U.S.C. ss.1161 et seq. (commonly known as "COBRA"),
          with the cost of the regular premium for such Benefits shared in the
          same relative proportion by the Company and the Executive as in effect
          on the date of termination (it being understood that such continuation
          of Benefit includes continued participation in the Sibson retirement
          plan as provided in Section 5(d) hereof);

          (iv) The Termination Benefits set forth in (i), (ii)(B) and (iii)
          above shall continue effective until the later of (x) the expiration
          of the Initial Term or (y) one (1) year from the date of the
          termination of the Executive's employment, and will include such
          payments for accrued vacation pay and any similar items required by
          law. Notwithstanding the foregoing, nothing in this Section 7(d) shall
          be construed to affect the Executive's right to receive COBRA
          continuation entirely at the Executive's own cost to the extent that
          the Executive may continue to be entitled to COBRA continuation after
          the Executive's right to cost sharing under Section 7(d)(iii) ceases;

          (v) Any options exercisable for Class A Common Stock granted to the
          Executive which are not vested at that time shall be deemed to have
          vested to the extent of one hundred percent (100%) of such remaining
          unvested portion;

          (vi) The Company shall pay seventy-five percent (75%) of the
          Executive's premiums for medical/health Benefits for the period from
          the date of termination of the Executive's employment under this
          Agreement until the Executive becomes eligible for full Medicare
          benefits. Such post-retirement medical/health Benefits shall be
          substantially similar in the aggregate to the medical/health Benefits
          for which the Executive was eligible during his period of employment
          with the Company;

                                       6
<PAGE>   7

          (vii) Executive will be released from the restrictions and covenants
          contained within the section entitled "Non-Compete/Exclusivity" under
          the Non-Compete Agreement executed by Executive, and upon termination
          of the payment of the Termination Benefits set forth in (i), (ii)(B)
          and (iii) above, Executive will be released from the restrictions and
          covenants contained within the section entitled "Non-Solicitation"
          under the Non-Compete Agreement executed by Executive; provided,
          however, that at Executive's option upon prior written notice to the
          Company, Executive shall be released from the restrictions and
          covenants contained within the section entitled "Non-Solicitation"
          under the Non-Compete Agreement executed by Executive, and the Company
          shall have no further liability or obligation for the payment of any
          remaining Termination Benefits under Sections 7(d)(i), 7(d)(ii)(B) and
          7(d)(iii) from and after the date of such notice, which Termination
          Benefits shall be forfeited by Executive; and

          (viii) In addition to the foregoing, in the event of the termination
          of the Executive's employment with the Company for any reason, the
          Executive shall be entitled to payment of any accrued and unpaid
          Benefits for which the Executive may otherwise be vested or entitled
          in accordance with the terms of the applicable plans governing such
          Benefits and to payment for reimbursable expenses under applicable
          Company policy within thirty (30) days of termination.

     (e) DISABILITY. At the election of the Company, this Agreement shall
     terminate on such date as may be selected by the Company after the
     Executive shall have failed to render and perform the services required of
     him under this Agreement during any period of 90 days within any 120 day
     period during the Term because of physical or mental disability. In the
     event of such termination, the Company shall have no further obligation for
     the payment of compensation or benefits hereunder, except (i) for
     compensation accrued and unpaid through the termination date and (ii) the
     payment of any disability insurance to which the Executive may be entitled.
     If there should be any dispute between the parties as to the Executive's
     physical or mental incapacity or disability pursuant to this Section 7(e),
     such question shall be settled by the opinion of an impartial reputable
     physician agreed upon for this purpose by the parties or their
     representatives, or failing agreement within ten (10) days after a written
     request therefor by any party to the other party, one selected in
     accordance with the rules of the American Arbitration Association. The
     certificate of such physician as to the matter in dispute shall be final
     and binding on the parties.

     (f) DEATH. In the event of termination as a result of the Executive's
     death, the Company shall have no further obligation to the Executive's
     representatives and heirs hereunder.

     (g) LEAVE OF ABSENCE UPON INDICTMENT. Upon indictment of the Executive for
     (A) a felony or (B) any misdemeanor involving moral turpitude, deceit,
     dishonesty or fraud ("indictment," for these purposes, meaning an
     indictment, probable cause hearing or any other procedure pursuant to which
     an initial determination of probable or reasonable cause with respect to
     such offense is made), the Board, at its option, may place the Executive on
     a paid leave of absence from employment for a period of up to six (6)

                                       7
<PAGE>   8

     months from such election. At the end of the six (6) month period if the
     indictment is pending, the Board may terminate the Executive for "Cause"
     effective immediately upon written notice to the Executive without further
     liability on the part of the Company. In making any determination under
     this Section 7(g), the Board shall act fairly and in good faith and shall
     give the Executive an opportunity to appear and be heard at a meeting of
     the Board or the compensation committee of the Board, which meeting may be
     held telephonically at the request of either the Company or the Executive,
     and present evidence on the Executive's behalf.

     (h) FAILURE TO RENEW AGREEMENT. In the event the Company elects not to
     extend the term of this Agreement as permitted by Section 3 and the
     Executive's employment is terminated, the Executive shall be entitled to
     the Termination Benefits described in Section 7(d). In the event that the
     Executive elects not to extend the Term of this Agreement as provided in
     Section 3 and the Executive's employment is terminated, the Executive shall
     be entitled to the termination benefits described in Sections 7(d)(vi) and
     7(d)(viii).

     8. NON-COMPETE, NON-SOLICITATION, PROPRIETARY INFORMATION, CONFIDENTIALITY
AND INVENTIONS AGREEMENTS.

     (a) The Executive agrees to sign the Non-Compete, Non-Solicitation,
     Proprietary Information, Confidentiality and Inventions Agreement, the form
     of which is attached hereto as Exhibit "A" and, except as set forth in
     Section 7(d)(vi), to comply with such Agreement during the Term.

     (b) LITIGATION AND REGULATORY COOPERATION. During the Executive's
     employment, the Executive shall cooperate fully with the Company in the
     defense or prosecution of any claims or actions now in existence or which
     may be brought in the future against or on behalf of the Company which
     relate to events or occurrences that transpired while the Executive was
     employed by the Company; provided, however, that the Executive shall be
     permitted to give testimony and appear as a witness in any proceeding in
     which such testimony or appearance is required by law. The Executive's full
     cooperation in connection with such claims or actions shall include, but
     not be limited to, being available to meet with counsel to prepare for
     discovery or trial and to act as a witness on behalf of the Company at
     mutually convenient times. During the Executive's employment, the Executive
     also shall cooperate fully with the Company in connection with any
     investigation or review of any federal, state or local regulatory authority
     as any such investigation or review relates to events or occurrences that
     transpired while the Executive was employed by the Company. The Executive
     also agrees to provide reasonable cooperation to the Company on matters of
     the type described in this Section 8(b) after termination of the
     Executive's employment. The Company shall reimburse the Executive for any
     reasonable out-of-pocket expenses incurred in connection with the
     Executive's performance of obligations pursuant to this Section 8(b).

     (c) REMEDIES. The Executive agrees that it would be difficult to measure
     any damages caused to the Company which might result from any breach by the
     Executive of the promises set forth in this Section 8, and that in any
     event money damages would be

                                       8
<PAGE>   9

     an inadequate remedy for any such breach. Accordingly, the Executive agrees
     that if the Executive breaches, or proposes to breach, any portion of this
     Section 8, the Company shall be entitled, in addition to all other remedies
     that it may have, to an injunction or other appropriate equitable relief to
     restrain any such breach without showing or proving any actual damage to
     the Company.

     9. GENERAL.

     (a) ARBITRATION OF DISPUTES. Any controversy or claim arising out of or
     relating to this Agreement or the breach thereof or otherwise arising out
     of the Executive's employment or the termination of that employment
     (including, without limitation, any claims of unlawful employment
     discrimination whether based on age or otherwise) shall, to the fullest
     extent permitted by law, be settled by arbitration in any forum and form
     agreed upon by the parties or, in the absence of such an agreement, under
     the auspices of the American Arbitration Association ("AAA") in New York,
     New York, the Employment Dispute Resolution Rules of the AAA, including,
     but not limited to, the rules and procedures applicable to the selection of
     arbitrators, except that the arbitrator shall apply the law as established
     by decisions of the U.S. Supreme Court and the federal and state courts
     sitting in New York in deciding the merits of claims and defenses under
     federal law or any state or federal anti-discrimination law, and any awards
     to the Executive for violation of any anti-discrimination law shall not
     exceed the maximum award to which the Executive could be entitled under the
     applicable (or most analogous) anti-discrimination or civil rights laws. In
     the event that any person or entity other than the Executive or the Company
     may be a party with regard to any such controversy or claim, such
     controversy or claim shall be submitted to arbitration subject to such
     other person or entity's agreement. Judgment upon the award rendered by the
     arbitrator may be entered in any court having jurisdiction thereof. The
     arbitrator shall have the authority to grant the prevailing party
     reasonable costs and expenses, including reasonable attorney's fees and the
     costs of the arbitration. This Section 9(a) shall be specifically
     enforceable. Notwithstanding the foregoing, this Section 9(a) shall not
     preclude either party from pursuing a court action for the sole purpose of
     obtaining a temporary restraining order or a preliminary injunction in
     circumstances in which such relief is appropriate; provided that any other
     relief shall be pursued through an arbitration proceeding pursuant to this
     Section 9(a).

     (b) INTEGRATION. This Agreement constitutes the entire agreement between
     the parties with respect to the subject matter hereof and supersedes all
     prior understandings and agreements between the parties, whether oral or
     written, with respect to any related subject matter.

     (c) ASSIGNMENT: SUCCESSORS AND ASSIGNS, ETC. Neither the Company nor the
     Executive may make any assignment of this Agreement or any interest herein,
     by operation of law or otherwise, without the prior written consent of the
     other party provided that the Company may assign its rights under this
     Agreement without the consent of the Executive in the event that the
     Company shall effect a reorganization, consolidate with or merge into any
     other corporation, partnership, organization or other entity, or transfer
     all or substantially all of its properties or assets to any other

                                        9

<PAGE>   10

     corporation, partnership, organization or other entity; provided such
     successor is the functional equivalent of the Company. This Agreement shall
     inure to the benefit of and be binding upon the Company and the Executive,
     their respective successors, executors, administrators, heirs and permitted
     assigns.

     (d) ENFORCEABILITY. If any portion or provision of this Agreement
     (including, without limitation, any portion or provision of any section of
     this Agreement) shall to any extent be declared illegal or unenforceable by
     a court of competent jurisdiction, then that court shall have the power to
     alter such provision to make it enforceable to the fullest extent permitted
     by law. The remainder of this Agreement, or the application of such portion
     or provision in circumstances other than those as to which it is so
     declared illegal or unenforceable, shall not be affected thereby, and each
     portion and provision of this Agreement shall be valid and enforceable to
     the fullest extent permitted by law.

     (e) WAIVER. No waiver of any provision hereof shall be effective unless
     made in writing and signed by the waiving party. The failure of any party
     to require the performance of any term or obligation of this Agreement, or
     the waiver by any party of any breach of this Agreement, shall not prevent
     any subsequent enforcement of such term or obligation or be deemed a waiver
     of any subsequent breach.

     (f) NOTICES. Any notices, requests, demands and other communications
     provided for by this Agreement shall be sufficient if in writing and
     delivered in person or sent by a nationally recognized overnight courier
     service or by registered or certified mail, postage prepaid, return receipt
     requested, to the Executive at the last address the Executive has filed in
     writing with the Company or, in the case of the Company, at its main
     offices, attention of the Chief Executive Officer, and shall be effective
     on the date of delivery in person or by courier or three (3) days after the
     date mailed.

     (g) AMENDMENT. This Agreement may be amended or modified only by a written
     instrument signed by the Executive and by a duly authorized representative
     of the Company.

     (h) COUNTERPARTS. This Agreement may be executed in any number of
     counterparts, each of which when so executed and delivered shall be taken
     to be an original; but such counterparts shall together constitute one and
     the same document.

     10. CONSENT TO JURISDICTION.

     (a) GOVERNING LAW. This contract shall be construed under and be governed
     in all respects by the laws of the State of New York without giving effect
     to the conflict of laws principles of such state.

     (b) CONSENT TO JURISDICTION. To the extent that any court action is
     permitted consistent with or to enforce Section 9(a) of this Agreement, the
     parties hereby consent to the jurisdiction of the state and federal courts
     in New York, New York. Accordingly, with respect to any such court action,
     each of the Executive and the Company (a) submits to the personal
     jurisdiction of such courts; (b) consents to service of process; and (c)
     waives

                                       10

<PAGE>   11

     any other requirement (whether imposed by statute, rule of court, or
     otherwise) with respect to personal jurisdiction or service of process.

     11. TERMINATION OF PRIOR EMPLOYMENT AGREEMENTS. All prior employment
agreements between the Executive and the Company or any of its subsidiaries or
affiliates, including, but not limited to, the Employment Agreement by and
between the Executive and Sibson, dated as of August 31, 1998 (the "1998
Employment Agreement"), are superseded by this Agreement and are terminated and
are null and void, except that the Executive shall be entitled to any accrued
and unpaid salary, bonus or benefits under the 1998 Employment Agreement through
the Effective Date.

                                       11

<PAGE>   12

     INTENDING TO BE LEGALLY BOUND by this Agreement and IN WITNESS THEREOF, the
undersigned parties have executed this Agreement as of this 30th day of
September, 2000.

                                            /s/ Vincent C. Perro
                                            -------------------------------
                                            State of Residence: New York
                                            -------------------------------

ACCEPTED:

NEXTERA ENTERPRISES, INC.

By: /s/ Michael P. Muldowney
------------------------------
Its: Chief Financial Officer

                                       12

<PAGE>   13

                                   SCHEDULE 1

                                    BENEFITS

     (A) MEDICAL: The supplemental medical reimbursement plan reimburses
Executive for deductibles, co-insurance amounts and expenses which are
reasonable and customary with respect to the Company's medical or dental plans.
Expenses for vision care are also covered. No more than $15,000 per family may
be reimbursed in any given calendar year.

     (B) LIFE INSURANCE: Executive may obtain whole life split-dollar insurance
with a death benefit equal to two times Salary. The policy is owned by the
Executive. The Company pays the premium and is entitled to that portion of the
cash value equal to the premium it has paid. Executive may also buy supplemental
term life. Participation in both the split-dollar plan and supplemental life
plan is subject to medical underwriting. Alternatively, the Company may make a
payment to a Executive in lieu of coverage under the split-dollar plan.

     (C) AUTOMOBILE: The Company will provide Executive with an automobile
allowance of $2,000 per month for the purpose of either leasing an automobile or
obtaining car service. The Executive agrees to assume the lease upon termination
of employment.

                                       13
<PAGE>   14

                                    EXHIBIT A

             NONCOMPETE, NON-SOLICITATION, PROPRIETARY INFORMATION,
                    CONFIDENTIALITY AND INVENTIONS AGREEMENT

     This Agreement is made as of September 30, 2000, by and between Nextera
Enterprises Inc., a Delaware corporation, and the undersigned Executive.
Executive and Nextera have also entered into an Employment Agreement of even
date herewith (the "Employment Agreement"). In consideration of the employment
and continued employment of Executive by Nextera Enterprises, Inc., its
successors, subsidiaries and affiliates (collectively, "Nextera"), the Executive
agrees to certain restrictions on activities necessary to avoid conflicts of
interest, ensure the exclusivity of Executive's services and protect the
goodwill, confidential information, and legitimate business interests of Nextera
and its clients. To further these objectives, the Executive agrees to comply
with the following provisions of this Agreement ("Agreement") as follows:

                             NONCOMPETE/EXCLUSIVITY

     During the period of employment by Nextera:

     1. the Executive will devote substantially all of the Executive's business
     time to the business of Nextera in accordance with Section 6 of the
     Executive's Employment Agreement with Nextera of even date herewith;

     2. will not engage in any business activity, current or proposed, which
     competes with the services or products being developed, marketed or sold by
     Nextera; and

     3. will not, without prior written consent of Nextera, invest in, enter
     into or assist any venture, enterprise, or endeavor which competes or
     intends to compete with Nextera, other than as a less than five percent
     (5%) stockholder of a publicly held company or a stockholder of a publicly
     held company which derives none or an immaterial portion (i.e., less than
     ten percent (10%)) of its revenues from services which compete with the
     services of Nextera.

The Executive represents that, to the best of the Executive's knowledge,
employment by Nextera will not conflict with any agreement to which the
Executive is subject.

                                NON-SOLICITATION

     1. The Executive acknowledges that the names and details of the firms with
     whom the Executive's has dealings while employed by Nextera constitute
     trade secrets

                                       1
<PAGE>   15

     belonging to Nextera. In order to preserve Nextera's trade secrets, during
     employment with Nextera and for a period of two (2) years after termination
     of the Executive's employment with Nextera for any reason, which two (2)
     year period or restrictions shall be reduced or eliminated as provided in
     the Employment Agreement in the event that Nextera terminates Executive's
     employment without Cause (as defined in the Employment Agreement) or
     Executive terminates his employment for Good Reason (as defined in the
     Employment Agreement):

          (a) the Executive will not solicit or cause to be solicited, or aid in
          the solicitation of business from firms for which the Executive did
          work or from whom the Executive actively solicited business during the
          Executive's employment with Nextera or any of its subsidiaries or
          affiliates; and

          (b) the Executive will not directly or indirectly contact or solicit
          any employee of Nextera with regard to present, future or contemplated
          employment opportunities on behalf of himself, or any other person,
          firm, corporation, governmental agency or other entity.

                             PROPRIETARY INFORMATION

     1. Proprietary Information refers to any information, not generally known
     in the relevant trade or industry, which was obtained from Nextera or any
     of its clients, past, present, or prospective, other than information that
     is or becomes known to the public or trade through no breach of this
     Agreement by the Executive.

     2. Proprietary Information includes, but is not limited to, the following
     items, whether or not labeled as such: customer lists, notes, drawings and
     writings; computer programs (including source and object codes),
     algorithms, systems, tools, spreadsheets, related documentation such as
     user manuals, functional and technical specifications, system descriptions,
     program documentation, output reports, terminal displays, and data file
     contents; plans, process and preparations for Nextera's current and
     proposed business activities; discoveries, inventions, developments, ideas,
     research, engineering, designs, and products; projects and improvements
     made or conceived in connection with Nextera's customer and prospective

                                       2
<PAGE>   16

     customer's lists; and marketing and financial data of Nextera and its
     clients.

     3. The Executive agrees not to disclose the existence of or contents of any
     documents, records, discs, tapes, and other media that contain Proprietary
     Information, and will not copy or remove any such material from Nextera or
     its client's premises, except as required by the Executive's duties or as
     approved by an authorized officer of Nextera.

     4. The Executive agrees to comply with all restrictions and regulations of
     Nextera's clients concerning any and all information such clients deem
     proprietary or confidential.

     5. The Executive agrees that any material relating to any matter within the
     scope of the business of Nextera, and any materials of clients of Nextera,
     is and shall remain the property of Nextera or such clients, as the case
     may be, and that upon termination of employment or at any earlier time as
     requested by Nextera, the Executive will immediately deliver such material
     and all copies in Executive's possession or control to Nextera or such
     clients, as the case may be.

     6. Nextera may provide the Executive with equipment (portable personal
     computer, software, etc.) for Executive's use in the course of employment
     by Nextera. The Executive acknowledges that any such equipment will remain
     the exclusive property of Nextera, and the Executive agrees to deliver such
     equipment to Nextera, as directed by Nextera, upon termination of
     employment for any reason, or at any time upon request of Nextera.

                                 CONFIDENTIALITY

     1. Except in connection with the Executive's duties for Nextera, the
     Executive will not use or disclose to anyone outside Nextera, and will not
     use any Proprietary Information or material relating to the business of
     Nextera, or its clients, either during or after employment by Nextera,
     except with the written permission of Nextera.

     2. The Executive will not disclose to Nextera, and will not induce Nextera
     to use any confidential information or material belonging to others where
     such disclosure would, to the Executive's knowledge, violate any rights of,
     or any duty owing to, a third party.

                                       3
<PAGE>   17

     3. The Executive agrees not to discuss any information or respond to any
     inquiries from the press or other information agencies regarding Nextera
     without the express permission of Nextera, other than responding in the
     ordinary course of business to inquiries regarding the consulting industry
     generally or work done for clients of Nextera.

     4. The Executive shall be permitted to give testimony and appear as a
     witness in any proceeding in which such testimony or appearance is required
     by law, provided the Executive reasonably furnishes notice to Nextera in
     order to enable Nextera to seek a protective order, if applicable.

                                   INVENTIONS

     1. The Executive agrees to disclose promptly and fully to Nextera all
     developments, inventions, discoveries, improvements, and proposals for new
     programs, systems, services, products, tools, or business endeavors which
     are related to any business activity by Nextera, current or proposed
     (collectively called "Developments").

     2. The Executive hereby assigns to Nextera the Executive's entire right,
     title, and interest in each and every work product or Development related
     to any business activity by Nextera, current or proposed (collectively
     called "Work Product"):

          (a) made, developed or conceived solely by the Executive or jointly
          with others during or in the course of the Executive's employment by
          Nextera,

          (b) made, developed or conceived wholly or partially as the result of
          any task assigned to the Executive or any work performed by the
          Executive for or on behalf of Nextera or its clients, and/or

          (c) made or developed with the use of Nextera facilities or equipment.

     3. The Executive agrees to grant to Nextera a right of first refusal to
     market on a mutually agreed royalty basis, and a perpetual non-exclusive
     license to use, each and every Work Product or Development made, developed
     or conceived by the Executive during employment by Nextera which is not
     covered under the preceding paragraph.

                                       4
<PAGE>   18

     4. During employment with Nextera, the Executive agrees to provide Nextera
     with copies of any manuscripts produced by the Executive relating to the
     business of Nextera or which refers to Nextera in any manner for approval
     by Nextera prior to submission for publication.

     5. The Executive does not, however, assign any Developments, if any,
     relating in any way to Nextera business which were made prior to employment
     with Nextera, which Developments, if any, are identified on Exhibit A,
     attached to this Agreement.

                                     GENERAL

     1. The Executive's obligations under this Agreement shall survive the
     termination of employment. The Executive understands that this Agreement
     does not create an obligation of Nextera or any other party to continue
     employment.

     2. Nextera shall have the unrestricted right to assign this Agreement to
     its parent company, its affiliates, and any and all successors in interest.

     3. It is agreed that Nextera may inform any person or entity subsequently
     employing or evidencing an intention to employ, Executive of the nature of
     the information Nextera asserts to be confidential, and may inform said
     person or entity of the existence of this Agreement, and provide to such
     persons or entity a copy of this Agreement.

     4. Any breach of this Agreement by the Executive may cause irreparable
     damage, and in the event of such a breach, Nextera shall have, in addition
     to any remedies at law, the right to an injunction to prevent or restrain a
     breach of the Executive's obligations hereunder.

     5. Nextera's failure to exercise any rights under this Agreement does not
     constitute a waiver of such right in the event of a subsequent violation of
     this Agreement.

     6. This Agreement shall be governed by the laws of the state of Executive's
     employment.

     7. In the event a court of competent jurisdiction shall determine that any
     provision in this Agreement is too restrictive in scope or duration, then
     that court shall have the power to alter such provision to make it
     enforceable

                                       5
<PAGE>   19

     to the fullest extent permitted by law. Such a determination shall not have
     the effect of rendering any other provision herein contained invalid.

                                       6

<PAGE>   20

     INTENDING TO BE LEGALLY BOUND by this Agreement and IN WITNESS THEREOF, the
undersigned parties have executed this Agreement as of this 30th day of
September, 2000.

                                           ---------------------------------

ACCEPTED:

NEXTERA ENTERPRISES, INC.

By:
    -------------------------------------------
Its:
     ------------------------------------------

                                       7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00017-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00017-of-00352.parquet"}]]